0001607062-19-000235.txt : 20190520 0001607062-19-000235.hdr.sgml : 20190520 20190520143534 ACCESSION NUMBER: 0001607062-19-000235 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 71 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190520 DATE AS OF CHANGE: 20190520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iGambit, Inc. CENTRAL INDEX KEY: 0001479681 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 113363609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53862 FILM NUMBER: 19838365 BUSINESS ADDRESS: STREET 1: 1050 W JERICHO TURNPIKE STREET 2: SUITE A CITY: SMITHTOWN STATE: NY ZIP: 11788 BUSINESS PHONE: 631-670-6777 MAIL ADDRESS: STREET 1: 1050 W JERICHO TURNPIKE STREET 2: SUITE A CITY: SMITHTOWN STATE: NY ZIP: 11788 10-Q 1 igmb033119form10q.htm FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

     

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly period ended March 31, 2019

     

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from                       to

 

Commission file number 000-53862

 

iGambit Inc.

(Exact name of small business issuer as specified in its charter) 

Delaware 11-3363609
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

 

1050 W. Jericho Turnpike, Suite A
Smithtown, New York 11787
(Address of Principal Executive Offices) (Zip Code)

 

(631) 670-6777
(Issuer’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

       
Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☒
    (Do not check if a smaller reporting company)  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐  No ☒

 

The Registrant had 387,553,890 (not including 10 million shares held in treasury) shares of the Registrant’s $0.001 par value common stock outstanding.

 

 1 

 

 

iGambit Inc.
Form 10-Q

 

  Page No.
Part I — Financial Information  
Item 1. Unaudited Financial Statements:     3
Condensed Consolidated Balance Sheets 3
Condensed Consolidated Statements of Operations 4
Condensed Consolidated Statements of Changes in Stockholders’ Equity 5
Condensed Consolidated Statements of Cash Flows 6
Notes to Condensed Consolidated Financial Statements 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
Item 3. Quantitative and Qualitative Disclosures About Market Risk 28
Item 4. Controls and Procedures 28
Part II — Other Information   
Item 1. Legal Proceedings 29
Item 1A. Risk Factors 29
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
Item 3. Defaults upon Senior Securities 29
Item 4. Removed and Reserved 29
Item 5. Other Information 29
Item 6. Exhibits 29

 2 

 

PART I – FINANCIAL INFORMATION

 

Item 1 – Financial Statements

 

IGAMBIT INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
 
       
   MARCH 31,  DECEMBER 31,
   2019  2018
ASSETS   
Current assets          
Cash  $7,036   $369 
Accounts receivable   10,366    14,871 
Inventory   26,988    27,073 
Total current assets   44,390    42,313 
Other assets          
Property and equipment, net   1,871    2,118 
Intangible assets, net   2,398,048    2,572,015 
Deposits   2,020    2,020 
   $2,446,329   $2,618,466 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current liabilities          
Accounts payable and accrued expenses  $570,331   $480,270 
Accrued interest on notes payable   20,939    32,265 
Amounts due to related parties   139,753    145,367 
Deferred revenue   5,467    9,192 
Notes payable   52,500    52,500 
Convertible notes payable, net   214,368    377,611 
Derivative liability   219,516    288,242 
Total current liabilities   1,222,874    1,385,447 
           
Stockholders' equity          
Preferred stock, $.001 par value; authorized - 100,000,000 shares; No shares issued and outstanding   —      —   
Common stock, $.001 par value; authorized - 800,000,000 shares; 361,577,519 and 214,859,994 shares issued and 351,577,519 and 204,859,994 shares outstanding (net of treasury shares) as of March 31, 2019 and December 31, 2018, respectively   361,577    214,860 
Additional paid-in capital   14,884,059    14,480,973 
Accumulated deficit   (13,022,181)   (12,462,814)
    2,223,455    2,233,019 
Less: Treasury stock; 10,000,000 shares, at cost   (1,000,000)   (1,000,000)
Total stockholders' equity   1,223,455    1,233,019 
   $2,446,329   $2,618,466 
           
See accompanying notes to the condensed consolidated financial statements.

 

 3 

 

 

IGAMBIT INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
THREE MONTHS ENDED MARCH 31,
(UNAUDITED)
 
       
    2019    2018 
Sales  $5,325   $4,192 
Cost of sales   8,207    7,930 
Gross profit (loss)   (2,882)   (3,738)
           
Operating expenses          
General and administrative expenses   190,264    234,264 
Amortization   173,967    173,967 
Total operating expenses   364,231    408,231 
Loss from operations   (367,113)   (411,969)
           
Other income (expenses)          
Change in fair value of derivative liability   (53,163)   (118,101)
Loss on extinguishment of debt   (5,838)   (63,699)
Interest expense   (133,253)   (16,264)
Total other income (expenses)   (192,254)   (198,064)
Net loss  $(559,367)  $(610,033)
           
Basic and fully diluted loss per common share:          
Net loss per common share  $(.00)  $(.01)
Weighted average common shares outstanding - basic and fully diluted   286,206,039    121,245,294 
           
See accompanying notes to the condensed consolidated financial statements.

 

 4 

 

 

IGAMBIT INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
THREE MONTHS ENDED MARCH 31, 2019 AND 2018
 
                   
    Common stock                     
    Shares    Amount    

Additional Paid-in

Capital

    

Accumulated

 Deficit

    

Treasury

Stock

    Totals 
Balances, December 31, 2018   214,859,994   $214,860   $14,480,973   $(12,462,814)  $(1,000,000)  $1,233,019 
Compensation for vested stock options   —      —      1,025    —      —      1,025 
Notes payable and accrued interest converted to common stock   146,717,525    146,717    402,061    —      —      548,778 
Net loss                  (559,367)        (559,367)
Balances, March 31, 2019   361,577,519   $361,577   $14,884,059   $(13,022,181)  $(1,000,000)  $1,223,455 
Balances, December 31, 2017   126,196,571   $126,196   $12,891,348   $(9,648,569)  $(1,000,000)  $2,368,975 
Common stock issued for cash   750,000    750    14,250    —      —      15,000 
Notes payable and accrued interest converted to common stock   5,344,180    5,345    342,758    —      —      348,103 
Net loss                  (610,033)        (610,033)
Balances, March 31, 2018   132,290,751   $132,291   $13,248,356   $(10,258,602)  $(1,000,000)  $2,122,045 
                               
See accompanying notes to the condensed consolidated financial statements.

 

 5 

 

 

IGAMBIT INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
THREE MONTHS ENDED MARCH 31,
(UNAUDITED)
       
       
    2019    2018 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(559,367)  $(610,033)
Adjustments to reconcile net loss to net cash used in operating activities          
Depreciation   247    432 
Amortization   173,967    173,967 
Non cash interest expense   132,482    15,527 
Stock-based compensation expense   1,025    —   
Loss on extinguishment of debt   5,838    63,699 
Change in fair value of derivative liability   53,163    118,101 
Changes in operating assets and liabilities:          
Accounts receivable   4,505    4,733 
Inventory   85    —   
Prepaid expenses and other current assets   —      16,856 
Accounts payable and accrued expenses   90,061    (52,761)
Deferred revenue   (3,725)   (3,725)
NET CASH USED IN OPERATING ACTIVITIES   (101,719)   (273,204)
           
CASH FLOWS FROM INVESTING ACTIVITIES:   —      —   
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from issuance of convertible debt   114,000    309,000 
Proceeds from sale of common stock   —      15,000 
Proceeds from related party loans   6,386    —   
Repayments of related party loans   (12,000)   —   
NET CASH PROVIDED BY FINANCING ACTIVITIES   108,386    324,000 
           
NET INCREASE IN CASH   6,667    50,796 
CASH - BEGINNING OF PERIOD   369    9,449 
CASH - END OF PERIOD  $7,036   $60,245 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:          
Cash paid during the period for:          
Interest  $771   $737 
Non-cash investing and financing activities:          
Debt discount related to derivative liability  $206,000   $43,249 
Notes payable converted to common stock   270,957    102,000 
Common stock issued in payment of accrued interest   18,177    12,346 
           
See accompanying notes to the condensed consolidated financial statements.

 

 6 

 

 

IGAMBIT INC.

Notes to Condensed Consolidated Financial Statements

Three Months Ended March 31, 2018 and 2019

(Unaudited)

 

Note 1 - Organization and Basis of Presentation

 

The consolidated financial statements presented are those of iGambit Inc., (the “Company”) and its wholly-owned subsidiary, HealthDatix, Inc. (“HealthDatix. The Company is a holding company which seeks out acquisitions of operating companies in technology markets. HealthDatix, Inc. is engaged in the business of streamlining the process of managing information in the document-intensive medical field for customers throughout the United States.

 

Interim Financial Statements

 

The following (a) condensed consolidated balance sheet as of December 31, 2018, which has been derived from audited financial statements, and (b) the unaudited condensed consolidated interim financial statements of the Company have been prepared in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2019 are not necessarily indicative of results that may be expected for the year ending December 31, 2019. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2018 included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on April 16, 2019.

 

Note 2 – Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.  All intercompany accounts and transactions have been eliminated.

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

 

 7 

 

 

Fair Value Measurements

 

The Company adopted the provisions of ASC Topic 820, Fair Value Measurements and Disclosures, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.

 

The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of our short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.

 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

 

Level 1 – quoted prices in active markets for identical assets or liabilities

 

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

 

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

 

The estimated fair value of the derivative liability was calculated using the Black-Scholes option pricing model. The Company uses Level 3 inputs to value its derivative liabilities. The following table provides a reconciliation of the beginning and ending balances for the major classes of assets and liabilities measured at fair value using significant unobservable inputs (Level 3) and reflects gains and losses for the three months ended March 31, 2019 and 2018.

 

   2019  2018
Liabilities:      
Balance of derivative liabilities - beginning of period  $288,242   $66,059 
Issued   273,450    43,249 
Converted   (395,339)   (227,409)
Change in fair value recognized in operations   53,163    118,101 
Balance of derivative liabilities - end of period  $219,516   $—   

 

 8 

 

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of is’ customers. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the three months ended March 31, 2019 and 2018.

 

iGambit is a holding company and has no sources of revenue.

 

 9 

 

 

HealthDatix’s revenues are derived primarily from its Software as a Service (SaaS) offerings that are rendered to healthcare providers.  HealthDatix recognizes revenues when the products or services have been provided or delivered, the fees charged are fixed or determinable, HealthDatix and its customers understand the specific nature and terms of the agreed upon transactions, and collectability is reasonably assured.

 

Advertising Costs

 

The Company expenses advertising costs as incurred. There were no advertising costs charged to operations for the three months ended March 31, 2019 and 2018, respectively.

 

Cash and Cash Equivalents

 

For purposes of reporting cash flows, cash and cash equivalents include checking and money market accounts and any highly liquid debt instruments purchased with a maturity of three months or less.

 

Accounts Receivable

 

The Company analyzes the collectability of accounts receivable from continuing operations each accounting period and adjusts its allowance for doubtful accounts accordingly.  A considerable amount of judgment is required in assessing the realization of accounts receivables, including the creditworthiness of each customer, current and historical collection history and the related aging of past due balances.  The Company evaluates specific accounts when it becomes aware of information indicating that a customer may not be able to meet its financial obligations due to deterioration of its financial condition, lower credit ratings, bankruptcy or other factors affecting the ability to render payment.

 

Inventory

 

Inventory consisting of finished products is stated at the lower of cost or net realizable value.

 

Property and equipment and depreciation

 

Property and equipment are stated at cost. Maintenance and repairs are charged to expense when incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income. Depreciation for both financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:

 

Office equipment and fixtures   5 - 7 years 
Computer hardware   5 years 
Computer software   3 years 
Development equipment   5 years 

 10 

 

Amortization

Intangible assets are amortized using the straight line method over the estimated lives of the respective assets as follows:

 

Software   5 years 
Technology license   5 years 
Purchased in process R&D   Indefinite 
Customer contracts   10 years 

 

Long-Lived Assets

 

The Company assesses the valuation of components of its property and equipment and other long-lived assets whenever events or circumstances dictate that the carrying value might not be recoverable. The Company bases its evaluation on indicators such as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements and other external market conditions or factors that may be present. If such factors indicate that the carrying amount of an asset or asset group may not be recoverable, the Company determines whether an impairment has occurred by analyzing an estimate of undiscounted future cash flows at the lowest level for which identifiable cash flows exist. If the estimate of undiscounted cash flows during the estimated useful life of the asset is less than the carrying value of the asset, the Company recognizes a loss for the difference between the carrying value of the asset and its estimated fair value, generally measured by the present value of the estimated cash flows.

 

Deferred Revenue

 

Deposits from customers are not recognized as revenues, but as liabilities, until the following conditions are met: revenues are realized when cash or claims to cash (receivable) are received in exchange for goods or services or when assets received in such exchange are readily convertible to cash or claim to cash or when such goods/services are transferred. When such income item is earned, the related revenue item is recognized, and the deferred revenue is reduced. To the extent revenues are generated from the Company’s support and maintenance services, the Company recognizes such revenues when services are completed and billed. The Company has received deposits from its various customers that have been recorded as deferred revenue and presented as current liabilities in the amount of $5,467 and $9,192 as of March 31, 2019 and December 31, 2018, respectively.

 

Stock-Based Compensation

 

The Company accounts for its stock-based awards granted under its employee compensation plan in accordance with ASC Topic No. 718-20, Awards Classified as Equity, which requires the measurement of compensation expense for all share-based compensation granted to employees and non-employee directors at fair value on the date of grant and recognition of compensation expense over the related service period for awards expected to vest.  The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock options and warrants. The Black-Scholes option pricing model requires the input of highly subjective assumptions including the expected stock price volatility of the Company’s common stock, the risk free interest rate at the date of grant, the expected vesting term of the grant, expected dividends, and an assumption related to forfeitures of such grants.  Changes in these subjective input assumptions can materially affect the fair value estimate of the Company’s stock options and warrants.

 

 11 

 

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic No. 740, Income Taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.

 

The Company applies the provisions of ASC Topic No. 740 for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the Company’s financial statements. In accordance with this provision, tax positions must meet a more-likely-than-not recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position.

 

Recent Accounting Pronouncements

 

We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.

 

Note 3 – Going Concern

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.  The Company has an accumulated deficit of $13,022,181, and a working capital deficit of $1,178,484 at March 31, 2019. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time.  The Company’s continuation as a going concern is dependent upon its ability to obtain necessary equity financing and ultimately from generating revenues from its newly acquired subsidiary to continue operations. The Company expects that working capital requirements will continue to be funded through a combination of its existing funds and further issuances of securities. Working capital requirements are expected to increase in line with the growth of the business. Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund operations over the next twelve months. The Company has no lines of credit or other bank financing arrangements. The Company has financed operations to date through the proceeds of a private placement of equity and debt instruments.  In connection with the Company’s business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) developmental expenses associated with a start-up business and (ii) marketing expenses. The Company intends to finance these expenses with further issuances of securities, and debt issuances. Thereafter, the Company expects it will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to current stockholders. Further, such securities might have rights, preferences or privileges senior to common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict business operations.

 

 12 

 

 

The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Note 4 – Property and Equipment

 

Property and equipment are carried at cost and consist of the following at March 31, 2019 and December 31, 2018:

 

   2019  2018
Office equipment and fixtures  $10,964   $10,964 
Less: Accumulated depreciation   9,093    8,846 
   $1,871   $2,118 

 

Depreciation expense of $247 and $432 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.

 

Note 5 – Intangible Assets

 

Intangible assets from the acquisitions of HealthDatix and ECSL consist of the following at March 31, 2019 and December 31, 2018:

 

   2019  2018  Life
Software  $156,925   $156,925    5 years 
Customer contracts   644,846    644,846    10 years 
FDA 510K clearance   1,396,000    1,396,000    5 years 
Technology license   1,000,000    1,000,000    5 years 
In process research and development   604,000    604,000    Indefinite 
    3,801,771    3,801,771      
Less: Accumulated amortization   1,403,723    1,229,756      
   $2,398,048   $2,572,015      

 

Amortization expense of $173,967 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.

 

 13 

 

 

Note 6 - Earnings (Loss) Per Common Share

 

The Company calculates net income (loss) per common share in accordance with ASC 260 “Earnings Per Share” (“ASC 260”). Basic and diluted net earnings (loss) per common share was determined by dividing net earnings (loss) applicable to common stockholders by the weighted average number of common shares outstanding during the period. The Company’s potentially dilutive shares, which include outstanding common stock options and common stock warrants, have not been included in the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 as the result would be anti-dilutive.  

 

   Three Months Ended
   March 31,
   2019  2018
Stock options   20,500,000    8,463,000 
Stock warrants   1,875,000    1,150,000 
Total shares excluded from calculation   22,375,000    9,613,000 

 

Note 7 – Stock Based Compensation

 

Options

 

In 2006, the Company adopted the 2006 Long-Term Incentive Plan (the "2006 Plan").   Awards granted under the 2006 Plan have a ten-year term and may be incentive stock options, non-qualified stock options or warrants. The awards are granted at an exercise price equal to the fair market value on the date of grant and generally vest over a three or four year period. The Plan expired on December 31, 2009, therefore as of March 31, 2019, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2006 plan.

 

The 2006 Plan provided for the granting of options to purchase up to 10,000,000 shares of common stock.  8,146,900 options have been issued under the plan to date of which 7,157,038 have been exercised and 692,962 have expired to date.  There were 296,900 options outstanding under the 2006 Plan on its expiration date of December 31, 2009. All options issued subsequent to this date were not issued pursuant to any plan.

 

 14 

 

 

Stock option activity during the three months ended March 31, 2019 and 2018 follows:

 

   Options
Outstanding		  Weighted Average Exercise Price 

Weighted Average Grant-Date

Fair Value

 

Weighted Average Remaining Contractual Life

(Years)

Options outstanding at December 31, 2017   8,463,000   $0.07   $0.07    7.41 
No option activity   —      —      —        
Options outstanding at  March 31, 2018   8,463,000   $0.07    0.07    7.16 
Options outstanding at  December 31, 2018   20,500,000    0.03    0.03    7.52 
No option activity   —      —      —        
Options outstanding at  March 31, 2019   20,500,000   $0.03   $0.03    7.27 

 

Options outstanding at March 31, 2019 consist of:

 

Date Issued 

Number

Outstanding

 

Number

Exercisable

 

Exercise

Price

 

Expiration

Date

June 6, 2014   250,000    250,000   $0.05   June 6, 2019
March 24, 2015   200,000    200,000   $0.01   March 24, 2020
April 6, 2017   600,000    600,000   $0.03   April 6, 2027
June 6, 2017   700,000    700,000   $0.07   June 6, 2022
June 6, 2017   6,500,000    6,500,000   $0.07   June 6, 2027
November 1, 2018   12,250,000    12,250,000   $0.01   November 1, 2028
Total   20,500,000    20,500,000         

 

 15 

 

 

Warrants

 

In addition to our 2006 Long Term Incentive Plan, we have issued and outstanding compensatory warrants to two consultants entitling the holders to purchase a total of 275,000 shares of our common stock at an average exercise price of $0.94 per share. Warrants to purchase 25,000 shares of common stock vest upon 6 months after the Company engages in an IPO, have an exercise price of $3.00 per share, and expire 2 years after the Company engages in an IPO. Warrants to purchase 250,000 shares of common stock vest 100,000 shares on issuance (June 1, 2009), and 50,000 shares on each of the following three anniversaries of the date of issuance, have exercise prices ranging from $0.50 per share to $1.15 per share, and expire on June 1, 2019. The issuance of the compensatory warrants was not submitted to our shareholders for their approval.

Warrant activity during the three months ended March 31, 2019 and 2018 follows:

 

   Warrants
Outstanding		  Weighted Average Exercise Price  Weighted Average Grant-Date Fair Value 

Weighted Average Remaining Contractual Life

(Years)

Warrants outstanding at December 31, 2017   400,000   $0.62   $0.10    3.27 
Warrant granted   750,000    0.05    —        
Warrants outstanding at March 31, 2018   1,150,000   $0.21   $0.10    3.64 
Warrants outstanding at December 31, 2018   1,875,000   $0.12   $0.12    3.24 
No warrant activity   —      —      —        
Warrants outstanding at March 31, 2019   1,875,000   $0.12   $0.12    3.00 

 

Warrants outstanding at March 31, 2019 consist of:

 

Dater Issued 

Number

Outstanding

 

Number

Exercisable

 

Exercise

Price

 

Expiration

Date

June 1, 2009   100,000    100,000   $0.50   June 1, 2019
June 1, 2009   50,000    50,000   $0.65   June 1, 2019
June 1, 2009   50,000    50,000   $0.85   June 1, 2019
June 1, 2009   50,000    50,000   $1.15   June 1, 2019
January 1, 2017   50,000    50,000   $0.25   October 10, 2021
January 1, 2017   50,000    50,000   $0.50   November 7, 2021
January 5, 2017   25,000    25,000   $0.50   January 5, 2022
February 5, 2018   750,000    750,000   $0.05   February 5, 2023
April 27, 2018   750,000    750,000   $0.05   April 27, 2023
Total   1,875,000    1,875,000         

 

 16 

 

 

Note 8 – Convertible Debt

 

Convertible Notes Payable

 

On January 10, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $240,000, convertible into shares of the Company’s common stock, and includes a back-ended note with principal of $120,000 that was funded on July 10, 2018. The back-ended Note, including accrued interest is due July 10, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 15 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted $66,000 of the principal balance and accrued interest of $4,995 to 44,490,002 shares of common stock. The balance of the note was $100,000 on March 31, 2019.

 

On March 6, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $126,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due March 6, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the lowest trading price during the 20 trading day period ending on the latest complete trading day prior to and including the conversion date. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $60,000 and accrued interest of $4,342 to 35,446,300 shares of common stock.

 

On May 3, 2018, the Company entered into a Convertible Promissory Note pursuant to which the Company borrowed in the aggregate principal amount of $83,500. The convertible note is due 12 months after issuance and bears interest at a rate of 8%. The Note is convertible into shares of common stock of the Company 180 days following the date of funding and thereafter. The conversion price shall be subject to a discount of 35% applied to the average of the three lowest closing bid prices of the Common Stock during the prior twenty (20) trading day period. The Investor will be limited to convert no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. At any time during the period beginning on the date of the Note and ending on the date which is 180 days thereafter, the Company may repay the Note by paying an amount equal to the then outstanding amount multiplied by 130%. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $53,957 and accrued interest of $4,600 to 25,674,344 shares of common stock.

 

On June 25, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $53,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due April 15, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $38,000 and accrued interest of $2,120 to 14,859,260 shares of common stock.

 

 17 

 

 

On August 13, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $53,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due May 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted the principal balance of the note and accrued interest of $2,120 to 26,247,619 shares of common stock.

 

On September 17, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $33,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due June 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

On January 3, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due October 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

On February 15, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due November 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

On March 29, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due February 15, 2020 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

The Company recorded a debt discount related to identified embedded derivatives relating to conversion features and a reset provisions (see Note 9) based fair values as of the inception date of the Notes. The calculated debt discount equaled the face of the 8% note dated January 10, 2018 and is being amortized and revalued over the term of the note. The calculated debt discount equaled the face of the 8% note dated March 6, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated May 3, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated June 25, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated August 13, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated September 17, 2018 and is being amortized and revalued over the term of the note. Interest expense on the convertible notes of $130,362 and $14,878 was recorded for the three months ended March 31, 2019 and 2018, respectively.

 

 18 

 

 

The Company issued convertible debentures in the amount of $75,000 to three individuals. The debentures are convertible into 75,000 shares of common stock for up to 5 years, at the holders’ option, at an exercise price of $.50 and $.25, respectively. The debentures mature on the earlier of the closing of a subsequent financing event by the Company resulting in gross proceeds of at least $10,000,000 or three years from the date of issuance. The debentures bear interest at a rate of 10%. A beneficial conversion feature was not recorded as the fair market value of the Company’s common stock was less than the exercise prices at the dates of issuance and through the end of the year. Interest expense on the convertible debentures of $2,120 and $1,829 was recorded for the three months ended March 31, 2019 and 2018, respectively.

 

Convertible notes payable at March 31, 2019 and December 31, 2018 are summarized as follows:

 

   2019  2018
Total face value of notes  $322,000   $478,957 
Less: Discount   107,632    101,346 
Balance  $214,368   $377,611 

 

Note 9 – Derivative Liability

 

The Company has determined that the conversion feature embedded in the convertible notes described in Note 8 contain a potential variable conversion amount which constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability at fair value, with a corresponding discount recorded to the associated debt. The excess of the derivative value over the face amount of the note is recorded immediately to interest expense at inception. The Company used the Binomial Option Pricing model to value the conversion features.

 

The Company used Level 3 inputs for its valuation methodology for the conversion option liability in determining the fair value using a Black-Scholes option-pricing model with the following assumption inputs:

 

    March 31,    December 31, 
    2019    2018 
Annual dividend yield   —      —   
Expected life (years)    0.78 - 1.0     0.77 - 1.0 
Risk-free interest rate    2.44% - 2.52%     2.07% - 2.57% 
Expected volatility    274% - 280%     257% - 293% 

 

Based upon ASC 840-15-25 (EITF Issue 00-19, paragraph 11) the Company has adopted a sequencing approach regarding the application of ASC 815-40 to its outstanding convertible notes. Pursuant to the sequencing approach, the Company evaluates its contracts based upon earliest issuance date.

 

 19 

 

 

Note 10 – Notes Payable

 

Notes payable at March 31, 2019 and December 31, 2018 consists of loans to HealthDatix from 3 individuals totaling $52,500. The loans do not bear interest and there are no specific terms for repayment.

 

Note 11 – Stock Transactions

 

Designation of Preferred Stock

 

On August 2, 2018, the Company filed a Certificate of Designation with the Delaware Division of Corporations whereby the Company designated a Series A Preferred Stock and issued 1,000 shares to the Company’s CEO. The holders of Series A Preferred Stock will have voting rights, when combined with their existing holdings of the Company’s common stock, that entitle them to have an aggregate of 51% of the votes eligible to be cast by all stockholders with respect to all matters brought before a vote of the stockholders of the Company.

 

Common Stock Issued

 

On August 8, 2018, the Board unanimously approved an amendment to the Company’s Articles of Incorporation to increase the number of shares of Common Stock which the Company is authorized to issue from Four hundred million (400,000,000) to Eight Hundred Million (800,000,000) shares of Common Stock, $0.001 par value per share.

 

In connection with the convertible notes payable (see Note 8 above) the noteholders converted $270,957 of principal balance and $18,177 of accrued interest to 146,717,525 shares of common stock during the three months ended March 31, 2019. The stock issued was determined based on the terms of the convertible notes.

 

Note 12 - Income Taxes

 

A full valuation allowance was recorded against the Company’s net deferred tax assets. A valuation allowance must be established if it is more likely than not that the deferred tax assets will not be realized. This assessment is based upon consideration of available positive and negative evidence, which includes, among other things, the Company’s most recent results of operations and expected future profitability. Based on the Company’s cumulative losses in recent years, a full valuation allowance against the Company’s deferred tax assets has been established as Management believes that the Company will not realize the benefit of those deferred tax assets.

 

 20 

 

 

Note 13 – Concentrations and Credit Risk

 

Sales and Accounts Receivable

 

HealthDatix had sales to three customers which accounted for approximately 24%, 17%, and 17%, respectively of HealthDatix’s total sales for the three months ended March 31, 2019. One customer accounted for approximately 96% of accounts receivable at March 31, 2019.

 

HealthDatix had sales to four customers which accounted for approximately 30%, 21%, 21%, and 19%, respectively of HealthDatix’s total sales for the three months ended March 31, 2018. One customer accounted for 100% of accounts receivable at March 31, 2018.

 

Cash

 

Cash is maintained at a major financial institution. Accounts held at U.S. financial institutions are insured by the FDIC up to $250,000. Cash balances could exceed insured amounts at any given time, however, the Company has not experienced any such losses. The Company did not have any interest-bearing accounts at March 31, 2019 and December 31, 2018, respectively.

 

Note 14 - Related Party Transactions

 

Amounts Due to Related Parties

 

Amounts due to related parties with balances of $139,753 and $145,367 at March 31, 2019 and December 31, 2018, respectively, do not bear interest and are payable on demand. The Company’s former subsidiary, Arcmail owed amounts on a credit card that is guaranteed by the husband of the Company’s Executive Vice President, who was held personally responsible by the credit card company for the unpaid balance.

 

Note 15 – Commitments and Contingencies

 

Lease Commitment

 

The Company is obligated under an operating lease for its premises in Smithtown, New York that expires on May 31, 2019. The lease was not renewed and the officers of the Company will provide office space to the Company at no charge.

 

Total future minimum annual lease payments under the lease for the years ending December 31 are as follows:

 

2019  $3,380 

 

Rent expense of $7,728 and $7,048 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.

 

 21 

 

 

Employment Arrangements With Executive Officers

 

Effective April 1, 2017, in connection with the acquisition of HealthDatix Inc., the Company entered into employment agreements with Jerry Robinson, MaryJo Robinson, and Kathleen Shepherd each under a three-year term at a base salary of $75,000 per year, bonuses based upon objectives set by the Company, and participation in all benefit programs generally made available to HealthDatix employees. The employment agreements restrict the executive officers from engaging in certain competitive activities for the greater of 60 months from the date of the agreements or two years following the termination of their respective employment.

 

Note 16 – Subsequent Events

 

Common Stock Issued

 

Subsequent to the end of the period through the date of the report, a noteholder converted $55,232 of principal and $1,691 of accrued interest to 35,966,371 shares of the Company’s common stock.

 

 22 

 

 

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

FORWARD LOOKING STATEMENTS

 

This Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, included or incorporated by reference in this Form 10-Q which address activities, events or developments that the Company expects or anticipates will or may occur in the future, including such things as future capital expenditures (including the amount and nature thereof), finding suitable merger or acquisition candidates, expansion and growth of the Company’s business and operations, and other such matters are forward-looking statements. These statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments as well as other factors it believes are appropriate in the circumstances.

 

 Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements. Factors that could adversely affect actual results and performance include, among others, potential fluctuations in quarterly operating results and expenses, government regulation, technology change and competition. Consequently, all of the forward-looking statements made in this Form 10-Q are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequence to or effects on the Company or its business or operations. The Company assumes no obligations to update any such forward-looking statements.

 

INTRODUCTION

 

Introduction

          

iGambit is a company focused on the medical technology markets. Our primary focus is the expansion of our subsidiary HealthDatix™ Inc.

 

HealthDatix is a medical technology company that provides end to end Software-as-a-Service solutions, services and products via our HealthDatix Platform that manages, reports, and analyzes critical data, enabling healthcare and commercial organizations to deliver positive member outcomes.

 

 23 

 

 

HealthDatix Platform Products and Services

 

Health Risk Assessment (HRA)

 

Our Health Risk Assessment (HRA) solution is a standardized method of collecting health risk data from patients or employees that can be used by Wellness Clinics, Insurance Companies, Third Party Administrators (TPA’s) and/or self insured companies to identify the health risks of their employee or patient population. Our HRA solution can be tailored to deliver the HRA and a Preventive Plan for all beneficiaries and their dependents.

 

Target Market : Insurance Companies, TPA’s and/or self-insured companies.

 

Annual Wellness Visit (AWV)

 

Our Annual Wellness Visit (AWV) solution allows for a mass check of patients with CMS to determine if and when they are eligible for an initial or subsequent AWV and identifies eligibility for other preventive screenings. Our proprietary algorithm determines a patients’ qualification for preventive screenings, health and lifestyle risks and if they have 2 or more qualifying chronic conditions that make them eligible for CCM. The program creates a 5-10 year preventive plan for the patient and meets all of CMS audit requirements to bill for the services. The AWV provides a proactive approach to patient care and increases practice revenue by identifying and executing CMS recommended screenings for the patient to catch early disease states before they become chronic conditions

 

Target Market: Medicare Programs including ACO’s, Primary Care Offices, Chronic Care Management and Non-Medicare including Wellness Clinics, Insurance Companies, Medicare Advantage Plans (MAP)

 

BioDatix HealthBand

 

Our BioDatix Health Band requires our Remote Patient Monitoring (RPM) solution that speaks to our FDA cleared Electronic House Call system. The BioDatix Health Band passively collects heart rate, blood pressure, blood oxygen every 15 minutes. It calculates sleep and steps and sends to our BioDatix iOS/Android app and then to our RPM solution.

 

Target Markets: Physician Groups, ACO’s, Healthcare Systems, Cardiovascular & Pulmonary Providers, Insurance Companies, Preventive Care for High Stress Jobs, Wellness Clinics.

 

BioDatix Remote Patient Monitoring

 

In addition to our BioDatix HealthBand, our RPM solution accepts data from multiple FDA approved devices on a patient’s health status, ie. blood pressure, weight, glucose levels, etc. It’s a product that is primarily for home bound patients that need remote monitoring vs. placement in a rehab center after hospital discharge. The information in our RPM solution can then be accessed by the physician/staff to determine the health status of the patient and whether or not a critical situation is at hand for the patient to go to the hospital, come in for a visit, or receive a nursing staff visit. 

 

Target Markets: Physician Groups, ACO’s, Healthcare Systems, Cardiovascular & Pulmonary Providers, Insurance Companies, Preventive Care for High Stress Jobs, Wellness Clinics.

 

 24 

 

 

HealthDatix - Chronic Care Management (CCM) Program

 

Centers for Medicaid and Medicare Services (CMS) introduced the Chronic Care Management (CCM) program in 2015 with the goal of filling patient care gaps and providing patient care at home.

 

HealthDatix Chronic Care Management (CCM) service was established to provide better care by engaging patients between visits by providing remote monitoring of patients. eat better, exercise more, take their medications, and live healthier lives.  The CCM program delivers 20 minutes of non-face-to-face care coordination to Medicare eligible beneficiaries with two or more chronic conditions.

 

Target Markets:  Physician Groups, ACO’s, Healthcare Systems

 

Assets. At March 31, 2019, we had $2,446,329 in total assets, compared to $2,618,466, at December 31, 2018. The decrease in total assets was primarily due to amortization of intangible assets from the acquisition of our HealthDatix subsidiary.

 

Liabilities. At March 31, 2019, our total liabilities were $1,222,874 compared to $1,385,447 at December 31, 2018. Our current liabilities at March 31, 2019 consisted of accounts payable and accrued expenses of $570,331, accrued interest on notes payable of $20,939, amounts due to related parties of $139,753, deferred revenue of $5,467, notes payable of $52,500, convertible notes payable of $214,368 and derivative liability of $219,516, whereas our total liabilities at December 31, 2018 consisted of current liabilities including accounts payable and accrued expenses of $480,270, accrued interest on notes payable of $32,265, amounts due to related parties of $145,367, deferred revenue of $9,192, notes payable of $52,500, convertible notes payable of $377,611 and derivative liability of $288,242.

 

Stockholders’ Equity. Our Stockholders’ Equity decreased to $1,223,455 at March 31, 2019 from $1,233,019 at December 31, 2018. This decrease was primarily due to an increase in accumulated deficit for the three months ended March 31, 2019.

 

Three Months Ended March 31, 2019 as Compared to Three Months Ended March 31, 2018

 

Revenues and Net Loss. We had $5,325 of revenue from our HealthDatix subsidiary and a net loss of $559,367 during the three months ended March 31, 2019, compared to revenue of $4,192 and a net loss of $610,033 for the three months ended March 31, 2018. The increase in revenue was due primarily to the revenue generated by our HealthDatix subsidiary.

 

 25 

 

 

General and Administrative Expenses. General and Administrative Expenses decreased to $190,264 for the three months ended March 31, 2019 from $234,264 for the three months ended March 31, 2018. For the three months ended March 31, 2019 our General and Administrative Expenses consisted of corporate administrative expenses of $30,381, legal and accounting fees of $24,455 employee benefits expenses (health and life insurance) of $3,215, payroll expenses of $109,746, contract labor of $10,000, and transfer agent fees of 12,467. For the three months ended March 31, 2018 our General and Administrative Expenses consisted of corporate administrative expenses of $44,315, legal and accounting fees of $18,110, employee benefits expenses (health and life insurance) of $10,268, marketing expenses of $16,675, payroll expenses of $105,086, contract labor expense of $12,200, commissions and fees expenses of $21,000, and exchange filing fees of $6,610. The decreases from the three months ended March 31, 2018 to the three months ended March 31, 2019 relate primarily due to: (i) a decrease in employee benefits; (ii) a decrease in commissions and fees expenses; (iii) a decrease in contract labor expense; (iv) a decrease in marketing expense; and (v) a decrease in general and administrative costs associated with the operation of our HealthDatix subsidiary. Costs associated with our officers’ salaries and the operation of our HealthDatix subsidiary are expected to increase going forward, as we expand the business operations of HealthDatix which would likely increase our corporate administrative expenses.

 

Other Income (Expense). We reported change in fair value of derivative liability of $53,163, loss on extinguishment of debt of $5,838, and interest expense of $133,253 for the three months ended March 31, 2019. We reported change in fair value of derivative liability of $118,101, loss on extinguishment of debt of $63,699, and interest expense of $16,264 for the three months ended March 31, 2018.

 

Liquidity and Capital Resources

 

General

 

As reflected in the accompanying consolidated financial statements, at March 31, 2019, we had $7,036 of cash and stockholders’ equity of $1,223,455. At December 31, 2018, we had $369 of cash and stockholders’ equity of $1,233,019.

 

Our primary capital requirements in 2019 are likely to arise from the expansion of our HealthDatix operations. It is not possible to quantify those costs at this point in time, in that they depend on HealthDatix’s business opportunities and the state of the overall economy. We anticipate raising capital in the private markets to cover any such costs, though there can be no guaranty we will be able to do so on terms we deem to be acceptable. We do not have any plans at this point in time to obtain a line of credit or other loan facility from a commercial bank.

 

While we believe in the viability of our strategy to improve HealthDatix’s sales volume, and in our ability to raise additional funds, there can be no assurances that we will be able to fully effectuate our business plan.

 

We believe we will continue to increase our cash position and liquidity for the foreseeable future. We believe we have enough capital to fund our present operations.

 

 26 

 

 

Cash Flow Activity

 

Net cash used in operating activities was $101,719, for the three months ended March 31, 2019, compared to $273,204 for the three months ended March 31, 2018. Our primary use of cash flows from operating activities was from net losses of $559,367 and $610,033 for the three months ended March 31, 2019 and 2018, respectively. Additional contributing factors to the change were from depreciation expense of $247, amortization expense of $173,967, non-cash interest expense of $132,482, stock based compensation of $1,025, a loss on extinguishment of debt of $5,838, change in fair value of derivative liability of $53,163, a decrease in accounts receivable of $4,505, a decrease in inventory of $85, an increase in accounts payable and accrued expenses of $90,061, and a decrease in deferred revenue $3,725.

 

There were no cash flows from investing activities for the three months ended March 31, 2019 and 2018, respectively.

 

Net Cash provided by financing activities was $108,386 for the three months ended March 31, 2019 compared to $324,000 for the three months ended March 31, 2018. The cash flows provided by financing activities for the three months ended March 31, 2019 was primarily from $114,000 in proceeds from convertible debt, $6,386 in proceeds from related party loans, and $12,000 in repayments of related party loans. The cash flows provided by financing activities for the three months ended March 31, 2018 was primarily from $309,000 in proceeds from convertible debt and $15,000 in proceeds from the sale of common stock.

 

Plan of Operation and Funding

 

We expect that working capital requirements will continue to be funded through a combination of our existing funds and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business. Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next twelve months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) developmental expenses associated with a start-up business and (ii) marketing expenses. We intend to finance these expenses with further issuances of securities, and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

 

 27 

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not Required.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q.

 

Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of March 31, 2019, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

 28 

 

 

PART II — OTHER INFORMATION

     

Item 1. Legal Proceedings.

 

From time-to-time, the Company is involved in various civil actions as part of its normal course of business. The Company is not a party to any litigation that is material to ongoing operations as defined in Item 103 of Regulation S-K as of the period ended March 31, 2019.

 

Item 1A. Risk Factors.

 

Not required

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None

     

Item 3. Defaults upon Senior Securities.

 

None

       

Item 4. Removed and Reserved.

       

Item 5. Other Information.

 

None

     

Item 6. Exhibits

 

Exhibit No.   Description
31.1   Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of the Interim Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
32.2   Certification of the Interim Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)

 

 29 

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on May 20, 2019.

 

  iGambit Inc.
   
  /s/ John Salerno  
  John Salerno 
  Chief Executive Officer 
   
   
  /s/ Elisa Luqman  
  Elisa Luqman 
  Chief Financial Officer and Principal Accounting Officer

 

 30 

 

 

Exhibit Index

 

Exhibit No.   Description
31.1   Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of the Interim Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)
32.2   Certification of the Interim Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (This exhibit shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)

 31 

 

 EX-31.1 2 ex31_1.htm EXHIBIT 31.1

Exhibit 31.1

Chief Executive Officer Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, John Salerno, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of iGambit Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

May 20, 2019 /s/ John Salerno  
 

Chief Executive Officer 

(Principal Executive Officer)
EX-31.2 3 ex31_2.htm EXHIBIT 31.2

Exhibit 31.2

 

Chief Financial Officer Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Elisa Luqman, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of iGambit Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

May 20, 2019 /s/ Elisa Luqman  
 

Chief Financial Officer 

(Principal Financial Officer)
EX-32.1 4 ex32_1.htm EXHIBIT 32.1

Exhibit 32.1

 

 

WRITTEN STATEMENT OF THE CHIEF EXECUTIVE OFFICER
Pursuant to 18 U.S.C. Section 1350
As adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002

 

Solely for the purposes of complying with 18 U.S.C. s.1350 as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002, I, the undersigned Chief Executive Officer of iGambit Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019, (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

   
   
May 20, 2019 /s/ John Salerno  
 

Chief Executive Officer

(Principal Executive Officer) 

EX-32.2 5 ex32_2.htm EXHIBIT 32.2

Exhibit 32.2

WRITTEN STATEMENT OF THE CHIEF FINANCIAL OFFICER
Pursuant to 18 U.S.C. Section 1350
As adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002

 

Solely for the purposes of complying with 18 U.S.C. s.1350 as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002, I, the undersigned Chief Financial Officer of iGambit Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019, (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

May 20, 2019 /s/ Elisa Luqman  
 

Chief Financial Officer

(Principal Financial Officer) 
EX-101.INS 6 igmb-20190331.xml XBRL INSTANCE FILE 0001479681 2019-01-01 2019-03-31 0001479681 2019-03-31 0001479681 2018-12-31 0001479681 igmb:ConvertibleNoteFiveMember 2019-03-31 0001479681 2018-01-01 2018-03-31 0001479681 igmb:OfficeEquipmentAndFixturesMember srt:MinimumMember 2019-01-01 2019-03-31 0001479681 igmb:OfficeEquipmentAndFixturesMember srt:MaximumMember 2019-01-01 2019-03-31 0001479681 igmb:ComputerHardwareMember 2019-01-01 2019-03-31 0001479681 igmb:ComputerSoftwareMember 2019-01-01 2019-03-31 0001479681 igmb:DevelopmentEquipmentMember 2019-01-01 2019-03-31 0001479681 igmb:SoftwareMember 2019-01-01 2019-03-31 0001479681 igmb:TechnologylicenseMember 2019-01-01 2019-03-31 0001479681 us-gaap:CustomerContractsMember 2019-01-01 2019-03-31 0001479681 igmb:FDA510KClearanceMember 2019-01-01 2019-03-31 0001479681 us-gaap:InProcessResearchAndDevelopmentMember 2019-01-01 2019-03-31 0001479681 igmb:SoftwareMember 2019-03-31 0001479681 us-gaap:CustomerContractsMember 2019-03-31 0001479681 igmb:FDA510KClearanceMember 2019-03-31 0001479681 igmb:TechnologylicenseMember 2019-03-31 0001479681 us-gaap:InProcessResearchAndDevelopmentMember 2019-03-31 0001479681 igmb:SoftwareMember 2018-12-31 0001479681 us-gaap:CustomerContractsMember 2018-12-31 0001479681 igmb:FDA510KClearanceMember 2018-12-31 0001479681 igmb:TechnologylicenseMember 2018-12-31 0001479681 us-gaap:InProcessResearchAndDevelopmentMember 2018-12-31 0001479681 us-gaap:StockOptionMember 2019-01-01 2019-03-31 0001479681 us-gaap:WarrantMember 2019-01-01 2019-03-31 0001479681 us-gaap:StockOptionMember 2018-01-01 2018-03-31 0001479681 us-gaap:WarrantMember 2018-01-01 2018-03-31 0001479681 igmb:Options1Member 2019-03-31 0001479681 igmb:Options2Member 2019-03-31 0001479681 igmb:Options3Member 2019-03-31 0001479681 igmb:Options4Member 2019-03-31 0001479681 igmb:Options5Member 2019-03-31 0001479681 igmb:Options6Member 2019-03-31 0001479681 2018-03-31 0001479681 2017-12-31 0001479681 igmb:Options1Member 2019-01-01 2019-03-31 0001479681 igmb:Options2Member 2019-01-01 2019-03-31 0001479681 igmb:Options3Member 2019-01-01 2019-03-31 0001479681 igmb:Options4Member 2019-01-01 2019-03-31 0001479681 igmb:Options5Member 2019-01-01 2019-03-31 0001479681 igmb:Options6Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants1Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants2Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants3Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants4Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants5Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants6Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants7Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants8Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants9Member 2019-01-01 2019-03-31 0001479681 igmb:Warrants1Member 2019-03-31 0001479681 igmb:Warrants2Member 2019-03-31 0001479681 igmb:Warrants3Member 2019-03-31 0001479681 igmb:Warrants4Member 2019-03-31 0001479681 igmb:Warrants5Member 2019-03-31 0001479681 igmb:Warrants6Member 2019-03-31 0001479681 igmb:Warrants7Member 2019-03-31 0001479681 igmb:Warrants8Member 2019-03-31 0001479681 igmb:Warrants9Member 2019-03-31 0001479681 igmb:NoteholderMember igmb:PrincipalMember 2019-01-01 2019-03-31 0001479681 igmb:NoteholderMember igmb:AccruedInterestMember 2019-01-01 2019-03-31 0001479681 us-gaap:SubsequentEventMember igmb:NoteholderMember igmb:PrincipalMember 2019-05-01 2019-05-15 0001479681 us-gaap:SubsequentEventMember igmb:NoteholderMember igmb:AccruedInterestMember 2019-05-01 2019-05-15 0001479681 igmb:ConvertibleNoteOneMember igmb:PrincipalMember 2017-03-01 2017-03-30 0001479681 igmb:ConvertibleNoteFiveMember igmb:PrincipalMember 2018-01-01 2018-01-10 0001479681 igmb:ConvertibleNoteFiveMember igmb:PrincipalMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteFiveMember igmb:AccruedInterestMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteSevenMember igmb:PrincipalMember 2018-03-01 2018-03-06 0001479681 igmb:ConvertibleNoteSevenMember igmb:PrincipalMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteSevenMember igmb:AccruedInterestMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteEightMember igmb:PrincipalMember 2018-05-01 2018-05-03 0001479681 igmb:ConvertibleNoteEightMember igmb:PrincipalMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteEightMember igmb:AccruedInterestMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteNineMember igmb:PrincipalMember 2018-06-01 2018-06-25 0001479681 igmb:ConvertibleNoteNineMember igmb:PrincipalMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteNineMember igmb:AccruedInterestMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteTenMember igmb:PrincipalMember 2018-08-01 2018-08-13 0001479681 igmb:ConvertibleNoteTenMember igmb:PrincipalMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteTenMember igmb:AccruedInterestMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteElevenMember igmb:PrincipalMember 2018-09-01 2018-09-17 0001479681 igmb:ConvertibleNoteTwelveMember 2019-01-01 2019-01-03 0001479681 igmb:ConvertibleNoteThirteenMember 2019-02-01 2019-02-15 0001479681 igmb:ConvertibleNoteFourteenMember 2019-03-01 2019-03-29 0001479681 igmb:NoteholderMember 2019-01-01 2019-03-31 0001479681 us-gaap:SubsequentEventMember igmb:NoteholderMember 2019-05-01 2019-05-15 0001479681 igmb:ConvertibleNoteFiveMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteSevenMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteEightMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteNineMember 2019-01-01 2019-03-31 0001479681 igmb:ConvertibleNoteTenMember 2019-01-01 2019-03-31 0001479681 srt:MinimumMember 2019-01-01 2019-03-31 0001479681 srt:MaximumMember 2019-01-01 2019-03-31 0001479681 srt:MinimumMember 2018-01-01 2018-03-31 0001479681 srt:MaximumMember 2018-01-01 2018-03-31 0001479681 us-gaap:SalesMember igmb:FirstCustomersMember 2019-01-01 2019-03-31 0001479681 us-gaap:SalesMember igmb:SecondCustomersMember 2019-01-01 2019-03-31 0001479681 us-gaap:AccountsReceivableMember igmb:OneCustomerMember 2019-01-01 2019-03-31 0001479681 us-gaap:SalesMember igmb:FirstCustomersMember 2018-01-01 2018-03-31 0001479681 us-gaap:SalesMember igmb:SecondCustomersMember 2018-01-01 2018-03-31 0001479681 us-gaap:SalesMember igmb:ThirdCustomerMember 2018-01-01 2018-03-31 0001479681 us-gaap:SalesMember igmb:FourthCustomerMember 2018-01-01 2018-03-31 0001479681 us-gaap:AccountsReceivableMember igmb:OneCustomerMember 2018-01-01 2018-03-31 0001479681 us-gaap:SalesMember igmb:ThirdCustomerMember 2019-01-01 2019-03-31 0001479681 us-gaap:CommonStockMember 2017-12-31 0001479681 us-gaap:CommonStockMember 2018-03-31 0001479681 us-gaap:CommonStockMember 2018-12-31 0001479681 us-gaap:CommonStockMember 2019-03-31 0001479681 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001479681 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001479681 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001479681 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001479681 us-gaap:RetainedEarningsMember 2017-12-31 0001479681 us-gaap:RetainedEarningsMember 2018-03-31 0001479681 us-gaap:RetainedEarningsMember 2018-12-31 0001479681 us-gaap:RetainedEarningsMember 2019-03-31 0001479681 us-gaap:TreasuryStockMember 2017-12-31 0001479681 us-gaap:TreasuryStockMember 2018-03-31 0001479681 us-gaap:TreasuryStockMember 2018-12-31 0001479681 us-gaap:TreasuryStockMember 2019-03-31 0001479681 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001479681 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001479681 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001479681 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001479681 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0001479681 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001479681 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001479681 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 10-Q 2019-03-31 false iGambit, Inc. 0001479681 igmb --12-31 Non-accelerated Filer 2019 Q1 .001 .001 .001 .001 100000000 100000000 0 0 0 0 800000000 800000000 10000000 10000000 Yes false true 100000 273450 43249 -395339 -227409 P5Y P7Y P5Y P3Y P5Y P5Y P5Y P10Y P5Y Indefinite 0 0 5467 9192 -1178484 10964 10964 9093 8846 3801771 3801771 156925 644846 1396000 1000000 604000 156925 644846 1396000 1000000 604000 1403723 1229756 2398048 2572015 173967 173967 22375000 9613000 20500000 1875000 8463000 1150000 20500000 20500000 250000 200000 600000 700000 6500000 12250000 8463000 8463000 0.03 0.03 0.05 0.01 0.03 0.07 0.07 0.01 0.07 0.07 0.03 0.03 0.07 0.07 P7Y6M7D P7Y4M28D P7Y3M8D P7Y1M27D 2014-06-06 2015-03-24 2017-04-06 2017-06-06 2017-06-06 2018-11-01 20500000 250000 200000 600000 700000 6500000 12250000 2019-06-06 2020-03-24 2027-04-06 2022-06-06 2027-06-06 2028-11-01 1875000 1875000 1150000 400000 0.12 0.12 0.21 0.62 0.12 0.12 0.1 0.1 P3Y2M27D P3Y3M8D P3Y P3Y7M21D 2009-06-01 2009-06-01 2009-06-01 2009-06-01 2017-01-01 2017-01-01 2017-01-05 2018-02-05 2018-04-27 1875000 100000 50000 50000 50000 50000 50000 25000 750000 750000 1875000 100000 50000 50000 50000 50000 50000 25000 750000 750000 0.5 0.65 0.85 1.15 0.25 0.5 0.5 0.05 0.05 322000 478957 107632 101346 214368 377611 270957 18177 55232 1691 75000 240000 66000 4995 126000 60000 4342 83500 53957 4600 53000 38000 2120 53000 53000 2120 33000 38000 38000 38000 146717525 35966371 44490002 35446300 25674344 14859260 26247619 0.00 0.00 P9M11D P1Y P9M7D P1Y 0.0244 0.0252 0.0207 0.0257 2.74 2.80 2.57 2.93 0.24 0.17 0.96 0.30 0.21 0.21 .19 1.00 0.17 250000 139753 145367 3380 7728 7048 P3Y 75000 387553890 219516 288242 0 66059 2019-06-01 2019-06-01 2019-06-01 2019-06-01 2021-10-10 2021-11-07 2022-01-05 2023-02-05 2023-04-27 130362 14878 2120 1829 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 2017-03-31 2018-06-25 2018-07-10 2019-03-06 2019-05-03 2019-04-15 2019-05-30 2019-06-30 2019-10-30 2019-11-30 2020-02-15 44390 42313 26988 27073 10366 14871 7036 369 2446329 2618466 2020 2020 2398048 2572015 1871 2118 1222874 1385447 219516 288242 52500 52500 5467 9192 139753 145367 20939 32265 570331 480270 2446329 2618466 1223455 1233019 2122045 2368975 126196 132291 214860 361577 12891348 13248356 14480973 14884059 -9648569 -10258602 -12462814 -13022181 -1000000 -1000000 -1000000 -1000000 1000000 1000000 2223455 2233019 -13022181 -12462814 14884059 14480973 361577 214860 0 0 361577519 214859994 351577519 204859994 -2882 -3738 8207 7930 5325 4192 -367113 -411969 364231 408231 173967 173967 190264 234264 -559367 -610033 -192254 -198064 133253 16264 -5838 -63699 -53163 -118101 0.00 -.01 286206039 121245294 -559367 -610033 -610033 -559367 1025 0 132482 15527 247 432 -101719 -273204 -3725 -3725 90061 -52761 0 16856 85 0 4505 4733 0 0 7036 369 60245 9449 6667 50796 108386 324000 6386 0 0 15000 114000 309000 18177 12346 270957 102000 206000 43249 12000 0 15000 750 14250 548778 348103 5345 342758 146717 402061 126196571 132290751 214859994 361577519 750000 5344180 146717525 1025 1025 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 - Organization and Basis of Presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements presented are those of iGambit Inc., (the &#8220;Company&#8221;) and its wholly-owned subsidiary, HealthDatix, Inc. (&#8220;HealthDatix. The Company is a holding company which seeks out acquisitions of operating companies in technology markets. HealthDatix, Inc. is engaged in the business of streamlining the process of managing information in the document-intensive medical field for customers throughout the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Interim Financial Statements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following (a) condensed consolidated balance sheet as of December 31, 2018, which has been derived from audited financial statements, and (b) the unaudited condensed consolidated interim financial statements of the Company have been prepared in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2019 are not necessarily indicative of results that may be expected for the year ending December 31, 2019. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2018 included in the Company&#8217;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on April 16, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Summary of Significant Accounting Policies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Principles of Consolidation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.&#160;&#160;All intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Use of Estimates in the Preparation of Financial Statements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Fair Value Measurements </u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of ASC Topic 820, <i>Fair Value Measurements and Disclosures, </i>which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of our short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify">Level 1 &#8211; quoted prices in active markets for identical assets or liabilities</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify">Level 2 &#8211; quoted prices for similar assets and liabilities in active markets or inputs that are observable</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify">Level 3 &#8211; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of the derivative liability was calculated using the Black-Scholes option pricing model. The Company uses Level 3 inputs to value its derivative liabilities. The following table provides a reconciliation of the beginning and ending balances for the major classes of assets and liabilities measured at fair value using significant unobservable inputs (Level 3) and reflects gains and losses for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Liabilities:</font></td> <td>&#160;</td> <td colspan="3">&#160;</td> <td>&#160;</td> <td colspan="3">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 58%; padding-left: 10pt"><font style="font-size: 10pt">Balance of derivative liabilities - beginning of period</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">288,242</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">66,059</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">273,450</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43,249</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Converted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(395,339</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(227,409</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; padding-left: 10pt"><font style="font-size: 10pt">Change in fair value recognized in operations</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">53,163</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">118,101</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Balance of derivative liabilities - end of period</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">219,516</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Convertible Instruments</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, <i>Derivatives and Hedging Activities.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Revenue Recognition</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective January 1, 2018, the Company adopted ASC 606 &#8212; Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 &#8212; Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of is&#8217; customers. There was no impact on the Company&#8217;s financial statements as a result of adopting Topic 606 for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">iGambit is a holding company and has no sources of revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HealthDatix&#8217;s revenues are derived primarily from its Software as a Service (SaaS) offerings that are rendered to healthcare providers.&#160; HealthDatix&#160;recognizes revenues when the products or services have been provided or delivered, the fees charged are fixed or determinable, HealthDatix and its customers understand the specific nature and terms of the agreed upon transactions, and collectability is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Advertising Costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses advertising costs as incurred. There were no advertising costs charged to operations for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Cash and Cash Equivalents</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of reporting cash flows, cash and cash equivalents include checking and money market accounts and any highly liquid debt instruments purchased with a maturity of three months or less.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Accounts Receivable</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes the collectability of accounts receivable from continuing operations each accounting period and adjusts its allowance for doubtful accounts accordingly.&#160; A considerable amount of judgment is required in assessing the realization of accounts receivables, including the creditworthiness of each customer, current and historical collection history and the related aging of past due balances.&#160; The Company evaluates specific accounts when it becomes aware of information indicating that a customer may not be able to meet its financial obligations due to deterioration of its financial condition, lower credit ratings, bankruptcy or other factors affecting the ability to render payment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Inventory</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consisting of finished products is stated at the lower of cost or net realizable value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 3pt; text-align: justify"><b><u>Property and equipment and depreciation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost. Maintenance and repairs are charged to expense when incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income. Depreciation for both financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%"><font style="font-size: 10pt">Office equipment and fixtures</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 43%; text-align: right"><font style="font-size: 10pt">5 - 7 years</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Computer hardware</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Computer software</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Development equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 13.5pt 0 0; text-align: justify"><b><u>Amortization</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 13.5pt 0 0; text-align: justify">Intangible assets are amortized using the straight line method over the estimated lives of the respective assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%"><font style="font-size: 10pt">Software</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 43%; text-align: right"><font style="font-size: 10pt">5 years</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Technology license</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Purchased in process R&#38;D</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">Indefinite</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Customer contracts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10 years</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Long-Lived Assets</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company assesses the valuation of components of its property and equipment and other long-lived assets whenever events or circumstances dictate that the carrying value might not be recoverable. The Company bases its evaluation on indicators such as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements and other external market conditions or factors that may be present. If such factors indicate that the carrying amount of an asset or asset group may not be recoverable, the Company determines whether an impairment has occurred by analyzing an estimate of undiscounted future cash flows at the lowest level for which identifiable cash flows exist. If the estimate of undiscounted cash flows during the estimated useful life of the asset is less than the carrying value of the asset, the Company recognizes a loss for the difference between the carrying value of the asset and its estimated fair value, generally measured by the present value of the estimated cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Deferred Revenue</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deposits from customers are not recognized as revenues, but as liabilities, until the following conditions are met: revenues are realized when cash or claims to cash (receivable) are received in exchange for goods or services or when assets received in such exchange are readily convertible to cash or claim to cash or when such goods/services are transferred. When such income item is earned, the related revenue item is recognized, and the deferred revenue is reduced. To the extent revenues are generated from the Company&#8217;s support and maintenance services, the Company recognizes such revenues when services are completed and billed. The Company has received deposits from its various customers that have been recorded as deferred revenue and presented as current liabilities in the amount of $5,467 and $9,192 as of March 31, 2019 and December 31, 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Stock-Based Compensation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its stock-based awards granted under its employee compensation plan in accordance with ASC Topic No. 718-20, <i>Awards Classified as Equity,</i> which requires the measurement of compensation expense for all share-based compensation granted to employees and non-employee directors at fair value on the date of grant and recognition of compensation expense over the related service period for awards expected to vest.&#160;&#160;The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock options and warrants. The Black-Scholes option pricing model requires the input of highly subjective assumptions including the expected stock price volatility of the Company&#8217;s common stock, the risk free interest rate at the date of grant, the expected vesting term of the grant, expected dividends, and an assumption related to forfeitures of such grants.&#160;&#160;Changes in these subjective input assumptions can materially affect the fair value estimate of the Company&#8217;s stock options and warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Income Taxes</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic No. 740, <i>Income Taxes</i>. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the provisions of ASC Topic No. 740 for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the Company&#8217;s financial statements<i>.</i> In accordance with this provision, tax positions must meet a more-likely-than-not recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Recent Accounting Pronouncements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Going Concern</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. &#160;The Company has an accumulated deficit of $13,022,181, and a working capital deficit of $1,178,484 at March 31, 2019. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time.&#160;&#160;The Company&#8217;s continuation as a going concern is dependent upon its ability to obtain necessary equity financing and ultimately from generating revenues from its newly acquired subsidiary to continue operations. The Company expects that working capital requirements will continue to be funded through a combination of its existing funds and further issuances of securities. Working capital requirements are expected to increase in line with the growth of the business. Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund operations over the next twelve months. The Company has no lines of credit or other bank financing arrangements. The Company has financed operations to date through the proceeds of a private placement of equity and debt instruments.&#160; In connection with the Company&#8217;s business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) developmental expenses associated with a start-up business and (ii) marketing expenses. The Company intends to finance these expenses with further issuances of securities, and debt issuances. Thereafter, the Company expects it will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to current stockholders. Further, such securities might have rights, preferences or privileges senior to common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict business operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Property and Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are carried at cost and consist of the following at March 31, 2019 and December 31, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Office equipment and fixtures</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,964</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,964</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Less: Accumulated depreciation</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">9,093</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">8,846</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,871</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,118</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense of $247 and $432 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8211; Intangible Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets from the acquisitions of HealthDatix and ECSL consist of the following at March 31, 2019 and December 31, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 46%; text-align: justify"><font style="font-size: 10pt">Software</font></td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">156,925</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">156,925</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 11%; text-align: center"><font style="font-size: 10pt">5 years</font></td> <td style="width: 1%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Customer contracts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">644,846</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">644,846</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">10 years</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">FDA 510K clearance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,396,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,396,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">5 years</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Technology license</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">5 years</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">In process research and development</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">604,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">604,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Indefinite</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,801,771</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,801,771</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Less: Accumulated amortization</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,403,723</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,229,756</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,398,048</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,572,015</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization expense of $173,967 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 - Earnings (Loss) Per Common Share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates net income (loss) per common share in accordance with ASC 260 &#8220;<i>Earnings Per Share</i>&#8221; (&#8220;ASC 260&#8221;). Basic and diluted net earnings (loss) per common share was determined by dividing net earnings (loss) applicable to common stockholders by the weighted average number of common shares outstanding during the period. The Company&#8217;s potentially dilutive shares, which include outstanding common stock options and common stock warrants, have not been included in the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 as the result would be anti-dilutive.&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="7" style="text-align: center"><font style="font-size: 10pt">Three Months Ended</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">March 31,</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Stock options</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">8,463,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Stock warrants</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,150,000</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total shares excluded from calculation</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">22,375,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,613,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8211; Stock Based Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Options</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2006, the Company adopted the 2006 Long-Term Incentive Plan (the &#34;2006 Plan&#34;).&#160;&#160; Awards granted under the 2006 Plan have a ten-year term and may be incentive stock options, non-qualified stock options or warrants. The awards are granted at an exercise price equal to the fair market value on the date of grant and generally vest over a three or four year period. The Plan expired on December 31, 2009, therefore as of March 31, 2019, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2006 plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 2006 Plan provided for the granting of options to purchase up to 10,000,000 shares of common stock.&#160;&#160;8,146,900 options have been issued under the plan to date of which 7,157,038 have been exercised and 692,962 have expired to date.&#160;&#160;There were 296,900 options outstanding under the 2006 Plan on its expiration date of December 31, 2009. All options issued subsequent to this date were not issued pursuant to any plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Stock option activity during the three months ended March 31, 2019 and 2018 follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Options </font><br /> <font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Weighted Average Exercise&#160;Price</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted Average Grant-Date</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Fair Value</p></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted Average Remaining Contractual Life</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Years)</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 44%; text-align: justify"><font style="font-size: 10pt">Options outstanding at December 31, 2017</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">8,463,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">7.41</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">No option activity</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Options outstanding at &#160;March 31, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,463,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7.16</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Options outstanding at &#160;December 31, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.03</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.03</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7.52</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">No option activity</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Options outstanding at &#160;March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.03</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.03</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7.27</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Options outstanding at March 31, 2019 consist of:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Date Issued</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercisable</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Expiration</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 22%; text-align: justify"><font style="font-size: 10pt">June 6, 2014</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 17%; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 6, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">March 24, 2015</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">March 24, 2020</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">April 6, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.03</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">April 6, 2027</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">June 6, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">700,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">700,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 6, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">June 6, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,500,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,500,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 6, 2027</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">November 1, 2018</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">12,250,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">12,250,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">0.01</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">November 1, 2028</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt; text-align: center">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Warrants</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to our 2006 Long Term Incentive Plan, we have issued and outstanding compensatory warrants to two consultants entitling the holders to purchase a total of 275,000 shares of our common stock at an average exercise price of $0.94 per share. Warrants to purchase 25,000 shares of common stock vest upon 6 months after the Company engages in an IPO, have an exercise price of $3.00 per share, and expire 2 years after the Company engages in an IPO. Warrants to purchase 250,000 shares of common stock vest 100,000 shares on issuance (June&#160;1, 2009), and 50,000 shares on each of the following three anniversaries of the date of issuance, have exercise prices ranging from $0.50 per share to $1.15 per share, and expire on June&#160;1, 2019. The issuance of the compensatory warrants was not submitted to our shareholders for their approval.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warrant activity during the three months ended March 31, 2019 and 2018 follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Warrants </font><br /> <font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Weighted Average Exercise&#160;Price</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Weighted Average Grant-Date Fair Value</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted Average Remaining Contractual Life</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Years)</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 44%; text-align: justify"><font style="font-size: 10pt">Warrants outstanding at December 31, 2017</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">400,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.62</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.10</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">3.27</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Warrant granted</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">750,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Warrants outstanding at March 31, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,150,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.21</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.10</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3.64</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Warrants outstanding at December 31, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.24</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">No warrant activity</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Warrants outstanding at March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3.00</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warrants outstanding at March 31, 2019 consist of:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Dater Issued</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercisable</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Expiration</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 22%; text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">100,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">100,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">0.50</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 17%; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.65</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.85</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.15</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">January 1, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">October 10, 2021</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">January 1, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.50</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">November 7, 2021</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">January 5, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.50</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">January 5, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">February 5, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.05</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">February 5, 2023</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">April 27, 2018</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">750,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">750,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">April 27, 2023</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt; text-align: center">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Convertible Debt</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Convertible Notes Payable</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 10, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $240,000, convertible into shares of the Company&#8217;s common stock, and includes a back-ended note with principal of $120,000 that was funded on July 10, 2018. The back-ended Note, including accrued interest is due July 10, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 15 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted $66,000 of the principal balance and accrued interest of $4,995 to 44,490,002 shares of common stock. The balance of the note was $100,000 on March 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 6, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $126,000, convertible into shares of the Company&#8217;s common stock. The Note, including accrued interest is due March 6, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the lowest trading price during the 20 trading day period ending on the latest complete trading day prior to and including the conversion date. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $60,000 and accrued interest of $4,342 to 35,446,300 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 3, 2018, the Company entered into a Convertible Promissory Note pursuant to which the Company borrowed in the aggregate principal amount of $83,500. The convertible note is due 12 months after issuance and bears interest at a rate of 8%. The Note is convertible into shares of common stock of the Company 180 days following the date of funding and thereafter. The conversion price shall be subject to a discount of 35% applied to the average of the three lowest closing bid prices of the Common Stock during the prior twenty (20) trading day period. The Investor will be limited to convert no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. At any time during the period beginning on the date of the Note and ending on the date which is 180 days thereafter, the Company may repay the Note by paying an amount equal to the then outstanding amount multiplied by 130%. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $53,957 and accrued interest of $4,600 to 25,674,344 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $53,000, convertible into shares of the Company&#8217;s common stock. The Note, including accrued interest is due April 15, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $38,000 and accrued interest of $2,120 to 14,859,260 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 13, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $53,000, convertible into shares of the Company&#8217;s common stock. The Note, including accrued interest is due May 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted the principal balance of the note and accrued interest of $2,120 to 26,247,619 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 17, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $33,000, convertible into shares of the Company&#8217;s common stock. The Note, including accrued interest is due June 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 3, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company&#8217;s common stock. The Note, including accrued interest is due October 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 15, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company&#8217;s common stock. The Note, including accrued interest is due November 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 29, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company&#8217;s common stock. The Note, including accrued interest is due February 15, 2020 and is convertible any time after 180 days at the option of the holder into shares of the Company&#8217;s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recorded a debt discount related to identified embedded derivatives relating to conversion features and a reset provisions (see Note 9) based fair values as of the inception date of the Notes. The calculated debt discount equaled the face of the 8% note dated January 10, 2018 and is being amortized and revalued over the term of the note. The calculated debt discount equaled the face of the 8% note dated March 6, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated May 3, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated June 25, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated August 13, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated September 17, 2018 and is being amortized and revalued over the term of the note. Interest expense on the convertible notes of $130,362 and $14,878 was recorded for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company issued convertible debentures in the amount of $75,000 to three individuals. The debentures are convertible into 75,000 shares of common stock for up to 5 years, at the holders&#8217; option, at an exercise price of $.50 and $.25, respectively. The debentures mature on the earlier of the closing of a subsequent financing event by the Company resulting in gross proceeds of at least $10,000,000 or three years from the date of issuance. The debentures bear interest at a rate of 10%. A beneficial conversion feature was not recorded as the fair market value of the Company&#8217;s common stock was less than the exercise prices at the dates of issuance and through the end of the year. Interest expense on the convertible debentures of $2,120 and $1,829 was recorded for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Convertible notes payable at March 31, 2019 and December 31, 2018 are summarized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Total face value of notes</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">322,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">478,957</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Less: Discount</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">107,632</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">101,346</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Balance</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">214,368</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">377,611</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Derivative Liability</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has determined that the conversion feature embedded in the convertible notes described in Note 8 contain a potential variable conversion amount which constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability at fair value, with a corresponding discount recorded to the associated debt. The excess of the derivative value over the face amount of the note is recorded immediately to interest expense at inception. The Company used the Binomial Option Pricing model to value the conversion features.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company used Level 3 inputs for its valuation methodology for the conversion option liability in determining the fair value using a Black-Scholes option-pricing model with the following assumption inputs:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">March 31,</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">December 31,</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Annual dividend yield</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Expected life (years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;0.78 - 1.0</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;0.77 - 1.0</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">Risk-free interest rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;2.44% - 2.52%</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;2.07% - 2.57%</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Expected volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;274% - 280%</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;257% - 293%</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based upon ASC 840-15-25 (EITF Issue 00-19, paragraph 11) the Company has adopted a sequencing approach regarding the application of ASC 815-40 to its outstanding convertible notes. Pursuant to the sequencing approach, the Company evaluates its contracts based upon earliest issuance date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10 &#8211; Notes Payable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable at March 31, 2019 and December 31, 2018 consists of loans to HealthDatix from 3 individuals totaling $52,500. The loans do not bear interest and there are no specific terms for repayment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 11 &#8211; Stock Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Designation of Preferred Stock</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 2, 2018, the Company filed a Certificate of Designation with the Delaware Division of Corporations whereby the Company designated a Series A Preferred Stock and issued 1,000 shares to the Company&#8217;s CEO. The holders of Series A Preferred Stock will have voting rights, when combined with their existing holdings of the Company&#8217;s common stock, that entitle them to have an aggregate of 51% of the votes eligible to be cast by all stockholders with respect to all matters brought before a vote of the stockholders of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Common Stock Issued</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 8, 2018, the Board unanimously approved an amendment to the Company&#8217;s Articles of Incorporation to increase the number of shares of Common Stock which the Company is authorized to issue from Four hundred million (400,000,000) to Eight Hundred Million (800,000,000) shares of Common Stock, $0.001 par value per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the convertible notes payable (see Note 8 above) the noteholders converted $270,957 of principal balance and $18,177 of accrued interest to 146,717,525 shares of common stock during the three months ended March 31, 2019. The stock issued was determined based on the terms of the convertible notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 12 - Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A full valuation allowance was recorded against the Company&#8217;s net deferred tax assets. A valuation allowance must be established if it is more likely than not that the deferred tax assets will not be realized. This assessment is based upon consideration of available positive and negative evidence, which includes, among other things, the Company&#8217;s most recent results of operations and expected future profitability. Based on the Company&#8217;s cumulative losses in recent years, a full valuation allowance against the Company&#8217;s deferred tax assets has been established as Management believes that the Company will not realize the benefit of those deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 13 &#8211; Concentrations and Credit Risk</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Sales and Accounts Receivable</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HealthDatix had sales to three customers which accounted for approximately 24%, 17%, and 17%, respectively of HealthDatix&#8217;s total sales for the three months ended March 31, 2019. One customer accounted for approximately 96% of accounts receivable at March 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HealthDatix had sales to four customers which accounted for approximately 30%, 21%, 21%, and 19%, respectively of HealthDatix&#8217;s total sales for the three months ended March 31, 2018. One customer accounted for 100% of accounts receivable at March 31, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Cash</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash is maintained at a major financial institution. Accounts held at U.S. financial institutions are insured by the FDIC up to $250,000. Cash balances could exceed insured amounts at any given time, however, the Company has not experienced any such losses. The Company did not have any interest-bearing accounts at March 31, 2019 and December 31, 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 14 - Related Party Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Amounts Due to Related Parties</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amounts due to related parties with balances of $139,753 and $145,367 at March 31, 2019 and December 31, 2018, respectively, do not bear interest and are payable on demand. The Company&#8217;s former subsidiary, Arcmail owed amounts on a credit card that is guaranteed by the husband of the Company&#8217;s Executive Vice President, who was held personally responsible by the credit card company for the unpaid balance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 15 &#8211; Commitments and Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Lease Commitment</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is obligated under an operating lease for its premises in Smithtown, New York that expires on May 31, 2019. The lease was not renewed and the officers of the Company will provide office space to the Company at no charge.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total future minimum annual lease payments under the lease for the years ending December 31 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%; text-align: justify"><font style="font-size: 10pt">2019</font></td> <td style="width: 10%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="width: 43%; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3,380</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense of $7,728 and $7,048 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Employment Arrangements With Executive Officers</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective April 1, 2017, in connection with the acquisition of HealthDatix Inc., the Company entered into employment agreements with Jerry Robinson, MaryJo Robinson, and Kathleen Shepherd each under a three-year term at a base salary of $75,000 per year, bonuses based upon objectives set by the Company, and participation in all benefit programs generally made available to HealthDatix employees. The employment agreements restrict the executive officers from engaging in certain competitive activities for the greater of 60 months from the date of the agreements or two years following the termination of their respective employment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 16 &#8211; Subsequent Events</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Common Stock Issued</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsequent to the end of the period through the date of the report, a noteholder converted $55,232 of principal and $1,691 of accrued interest to 35,966,371 shares of the Company&#8217;s common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Principles of Consolidation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.&#160;&#160;All intercompany accounts and transactions have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Use of Estimates in the Preparation of Financial Statements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Fair Value Measurements </u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of ASC Topic 820, <i>Fair Value Measurements and Disclosures, </i>which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of our short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify">Level 1 &#8211; quoted prices in active markets for identical assets or liabilities</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify">Level 2 &#8211; quoted prices for similar assets and liabilities in active markets or inputs that are observable</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify">Level 3 &#8211; inputs that are unobservable (for example cash flow modeling inputs based on assumptions)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of the derivative liability was calculated using the Black-Scholes option pricing model. The Company uses Level 3 inputs to value its derivative liabilities. The following table provides a reconciliation of the beginning and ending balances for the major classes of assets and liabilities measured at fair value using significant unobservable inputs (Level 3) and reflects gains and losses for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Liabilities:</font></td> <td>&#160;</td> <td colspan="3">&#160;</td> <td>&#160;</td> <td colspan="3">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 58%; padding-left: 10pt"><font style="font-size: 10pt">Balance of derivative liabilities - beginning of period</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">288,242</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">66,059</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">273,450</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43,249</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Converted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(395,339</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(227,409</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; padding-left: 10pt"><font style="font-size: 10pt">Change in fair value recognized in operations</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">53,163</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">118,101</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Balance of derivative liabilities - end of period</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">219,516</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Convertible Instruments</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, <i>Derivatives and Hedging Activities.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Revenue Recognition</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective January 1, 2018, the Company adopted ASC 606 &#8212; Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 &#8212; Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of is&#8217; customers. There was no impact on the Company&#8217;s financial statements as a result of adopting Topic 606 for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 157.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">iGambit is a holding company and has no sources of revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HealthDatix&#8217;s revenues are derived primarily from its Software as a Service (SaaS) offerings that are rendered to healthcare providers.&#160; HealthDatix&#160;recognizes revenues when the products or services have been provided or delivered, the fees charged are fixed or determinable, HealthDatix and its customers understand the specific nature and terms of the agreed upon transactions, and collectability is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Advertising Costs</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses advertising costs as incurred. There were no advertising costs charged to operations for the three months ended March 31, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Cash and Cash Equivalents</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of reporting cash flows, cash and cash equivalents include checking and money market accounts and any highly liquid debt instruments purchased with a maturity of three months or less.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Accounts Receivable</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company analyzes the collectability of accounts receivable from continuing operations each accounting period and adjusts its allowance for doubtful accounts accordingly.&#160; A considerable amount of judgment is required in assessing the realization of accounts receivables, including the creditworthiness of each customer, current and historical collection history and the related aging of past due balances.&#160; The Company evaluates specific accounts when it becomes aware of information indicating that a customer may not be able to meet its financial obligations due to deterioration of its financial condition, lower credit ratings, bankruptcy or other factors affecting the ability to render payment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Inventory</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consisting of finished products is stated at the lower of cost or net realizable value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 3pt; text-align: justify"><b><u>Property and equipment and depreciation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are stated at cost. Maintenance and repairs are charged to expense when incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income. Depreciation for both financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%"><font style="font-size: 10pt">Office equipment and fixtures</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 43%; text-align: right"><font style="font-size: 10pt">5 - 7 years</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Computer hardware</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Computer software</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Development equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 13.5pt 0 0; text-align: justify"><b><u>Amortization</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 13.5pt 0 0; text-align: justify">Intangible assets are amortized using the straight line method over the estimated lives of the respective assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%"><font style="font-size: 10pt">Software</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 43%; text-align: right"><font style="font-size: 10pt">5 years</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Technology license</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Purchased in process R&#38;D</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">Indefinite</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Customer contracts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10 years</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Long-Lived Assets</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company assesses the valuation of components of its property and equipment and other long-lived assets whenever events or circumstances dictate that the carrying value might not be recoverable. The Company bases its evaluation on indicators such as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements and other external market conditions or factors that may be present. If such factors indicate that the carrying amount of an asset or asset group may not be recoverable, the Company determines whether an impairment has occurred by analyzing an estimate of undiscounted future cash flows at the lowest level for which identifiable cash flows exist. If the estimate of undiscounted cash flows during the estimated useful life of the asset is less than the carrying value of the asset, the Company recognizes a loss for the difference between the carrying value of the asset and its estimated fair value, generally measured by the present value of the estimated cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Deferred Revenue</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deposits from customers are not recognized as revenues, but as liabilities, until the following conditions are met: revenues are realized when cash or claims to cash (receivable) are received in exchange for goods or services or when assets received in such exchange are readily convertible to cash or claim to cash or when such goods/services are transferred. When such income item is earned, the related revenue item is recognized, and the deferred revenue is reduced. To the extent revenues are generated from the Company&#8217;s support and maintenance services, the Company recognizes such revenues when services are completed and billed. The Company has received deposits from its various customers that have been recorded as deferred revenue and presented as current liabilities in the amount of $5,467 and $9,192 as of March 31, 2019 and December 31, 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Stock-Based Compensation</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its stock-based awards granted under its employee compensation plan in accordance with ASC Topic No. 718-20, <i>Awards Classified as Equity,</i> which requires the measurement of compensation expense for all share-based compensation granted to employees and non-employee directors at fair value on the date of grant and recognition of compensation expense over the related service period for awards expected to vest.&#160;&#160;The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock options and warrants. The Black-Scholes option pricing model requires the input of highly subjective assumptions including the expected stock price volatility of the Company&#8217;s common stock, the risk free interest rate at the date of grant, the expected vesting term of the grant, expected dividends, and an assumption related to forfeitures of such grants.&#160;&#160;Changes in these subjective input assumptions can materially affect the fair value estimate of the Company&#8217;s stock options and warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><u>Income Taxes</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic No. 740, <i>Income Taxes</i>. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the provisions of ASC Topic No. 740 for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the Company&#8217;s financial statements<i>.</i> In accordance with this provision, tax positions must meet a more-likely-than-not recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><u>Recent Accounting Pronouncements</u></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table provides a reconciliation of the beginning and ending balances for the major classes of assets and liabilities measured at fair value using significant unobservable inputs (Level 3) and reflects gains and losses for the three months ended March 31, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Liabilities:</font></td> <td>&#160;</td> <td colspan="3">&#160;</td> <td>&#160;</td> <td colspan="3">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 58%; padding-left: 10pt"><font style="font-size: 10pt">Balance of derivative liabilities - beginning of period</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">288,242</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">66,059</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">273,450</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">43,249</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Converted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(395,339</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(227,409</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; padding-left: 10pt"><font style="font-size: 10pt">Change in fair value recognized in operations</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">53,163</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">118,101</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Balance of derivative liabilities - end of period</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">219,516</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation for both financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%"><font style="font-size: 10pt">Office equipment and fixtures</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 43%; text-align: right"><font style="font-size: 10pt">5 - 7 years</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Computer hardware</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Computer software</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Development equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 13.5pt 0 0; text-align: justify">Intangible assets are amortized using the straight line method over the estimated lives of the respective assets as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%"><font style="font-size: 10pt">Software</font></td> <td style="width: 10%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 43%; text-align: right"><font style="font-size: 10pt">5 years</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Technology license</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td><font style="font-size: 10pt">Purchased in process R&#38;D</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">Indefinite</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Customer contracts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">10 years</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are carried at cost and consist of the following at March 31, 2019 and December 31, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Office equipment and fixtures</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,964</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,964</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Less: Accumulated depreciation</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">9,093</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">8,846</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,871</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,118</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets from the acquisitions of HealthDatix and ECSL consist of the following at March 31, 2019 and December 31, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 46%; text-align: justify"><font style="font-size: 10pt">Software</font></td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">156,925</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">156,925</font></td> <td style="width: 1%">&#160;</td> <td style="width: 5%">&#160;</td> <td style="width: 1%; text-align: center">&#160;</td> <td style="width: 11%; text-align: center"><font style="font-size: 10pt">5 years</font></td> <td style="width: 1%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Customer contracts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">644,846</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">644,846</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">10 years</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">FDA 510K clearance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,396,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,396,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">5 years</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Technology license</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">5 years</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">In process research and development</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">604,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">604,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">Indefinite</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,801,771</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,801,771</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Less: Accumulated amortization</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,403,723</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,229,756</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,398,048</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,572,015</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s potentially dilutive shares, which include outstanding common stock options and common stock warrants, have not been included in the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 as the result would be anti-dilutive.&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="7" style="text-align: center"><font style="font-size: 10pt">Three Months Ended</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">March 31,</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Stock options</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">8,463,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Stock warrants</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">1,150,000</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total shares excluded from calculation</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">22,375,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,613,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock option activity during the three months ended March 31, 2019 and 2018 follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Options </font><br /> <font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Weighted Average Exercise&#160;Price</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted Average Grant-Date</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Fair Value</p></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted Average Remaining Contractual Life</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Years)</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 44%; text-align: justify"><font style="font-size: 10pt">Options outstanding at December 31, 2017</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">8,463,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">7.41</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">No option activity</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Options outstanding at &#160;March 31, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,463,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.07</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7.16</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Options outstanding at &#160;December 31, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.03</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.03</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7.52</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">No option activity</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Options outstanding at &#160;March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.03</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.03</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7.27</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Options outstanding at March 31, 2019 consist of:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Date Issued</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercisable</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Expiration</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 22%; text-align: justify"><font style="font-size: 10pt">June 6, 2014</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">250,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 17%; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 6, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">March 24, 2015</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">March 24, 2020</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">April 6, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">600,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.03</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">April 6, 2027</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">June 6, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">700,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">700,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 6, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">June 6, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,500,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,500,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.07</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 6, 2027</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">November 1, 2018</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">12,250,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">12,250,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">0.01</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">November 1, 2028</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">20,500,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt; text-align: center">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warrant activity during the three months ended March 31, 2019 and 2018 follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Warrants </font><br /> <font style="font-size: 10pt">Outstanding</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Weighted Average Exercise&#160;Price</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Weighted Average Grant-Date Fair Value</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Weighted Average Remaining Contractual Life</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Years)</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 44%; text-align: justify"><font style="font-size: 10pt">Warrants outstanding at December 31, 2017</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">400,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.62</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">0.10</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">3.27</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Warrant granted</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">750,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Warrants outstanding at March 31, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,150,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.21</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.10</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3.64</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Warrants outstanding at December 31, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.12</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.24</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">No warrant activity</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Warrants outstanding at March 31, 2019</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.12</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3.00</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warrants outstanding at March 31, 2019 consist of:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">Dater Issued</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outstanding</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercisable</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Exercise</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Price</p></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Expiration</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date</p></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 22%; text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">100,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">100,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">0.50</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 17%; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.65</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.85</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">June 1, 2009</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.15</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">June 1, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">January 1, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">October 10, 2021</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">January 1, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.50</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">November 7, 2021</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">January 5, 2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">25,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.50</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">January 5, 2022</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">February 5, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.05</font></td> <td>&#160;</td> <td>&#160;</td> <td style="padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">February 5, 2023</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">April 27, 2018</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">750,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">750,000</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">0.05</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt; padding-left: 0.75pt; text-align: center"><font style="font-size: 10pt">April 27, 2023</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify"><font style="font-size: 10pt">Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,875,000</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; padding-left: 0.75pt; text-align: center">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Convertible notes payable at March 31, 2019 and December 31, 2018 are summarized as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Total face value of notes</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">322,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">478,957</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify"><font style="font-size: 10pt">Less: Discount</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">107,632</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">101,346</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Balance</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">214,368</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">377,611</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company used Level 3 inputs for its valuation methodology for the conversion option liability in determining the fair value using a Black-Scholes option-pricing model with the following assumption inputs:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-left: 5.4pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">March 31,</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">December 31,</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td style="padding-bottom: 1pt; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Annual dividend yield</font></td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="width: 1%">&#160;</td> <td style="width: 8%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#8212;&#160;&#160;</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Expected life (years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;0.78 - 1.0</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;0.77 - 1.0</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: silver"> <td style="text-align: justify"><font style="font-size: 10pt">Risk-free interest rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;2.44% - 2.52%</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;2.07% - 2.57%</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Expected volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;274% - 280%</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">&#160;257% - 293%</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total future minimum annual lease payments under the lease for the years ending December 31 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: silver"> <td style="width: 45%; text-align: justify"><font style="font-size: 10pt">2019</font></td> <td style="width: 10%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="width: 43%; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3,380</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"></p> 771 737 EX-101.SCH 7 igmb-20190331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Note 1 - Organization and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Note 3 - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Note 4 - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Note 5 - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Note 6 - Earnings (Loss) Per Common Share link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Note 7 - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Note 8 - Convertible Debt link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Note 9 - Derivative Liability link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Note 10 - Note Payable link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Note 11 - Stock Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Note 12 - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Note 13 - Concentrations and Credit Risk link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Note 14 - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Note 15 - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Note 16 - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Note 4 - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Note 5 - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Note 6 - Earnings (Loss) Per Common Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Note 7 - Stock Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Note 8 - Convertible Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Note 9 - Derivative Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Note 15 - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Narratives) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Note 3 - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Note 4 - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Note 4 - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Note 5 - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Note 5 - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Note 6 - Earnings (Loss) Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Note 7 - Stock Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Note 7 - Stock Based Compensation (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Note 7 - Stock Based Compensation (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Note 7 - Stock Based Compensation (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Note 8 - Convertible Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Note 8 - Convertible Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Note 9 - Derivative Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Note 10 - Note Payable (Details Narratives) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Note 11 - Stock Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Note 13 - Concentrations and Credit Risk (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Note 14 - Related Party Transactions (Details Narratives) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Note 15 - Commitments And Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Note 15 - Commitments and Contingencies (Details Narratives) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Note 16- Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 igmb-20190331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 igmb-20190331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 igmb-20190331_lab.xml XBRL LABEL FILE Short-term Debt, Type [Axis] ConvertibleNoteFiveMember Property, Plant and Equipment, Type [Axis] Office equipment and fixtures Range [Axis] Minimum Maximum Computer hardware Computer software Development equipment Finite-Lived Intangible Assets by Major Class [Axis] Software Technology license Customer contracts FDA 510K clearance In process research and development Antidilutive Securities [Axis] Options Warrant Award Type [Axis] Options One Options Two Options Three Options Four Options Five Options Six Warrants One Warrants Two Warrants Three Warrants Four Warrants Five Warrants Six Warrants Seven Warrants Eight Warrants Nine Noteholder Debt Security Category [Axis] Principal Accrued interest Subsequent Event Type [Axis] Subsequent Event [Member] 8% Convertible Note ConvertibleNoteSevenMember ConvertibleNoteEightMember ConvertibleNoteNineMember ConvertibleNoteTenMember ConvertibleNoteElevenMember ConvertibleNoteTwelveMember ConvertibleNoteThirteenMember ConvertibleNoteFourteenMember Concentration Risk Benchmark [Axis] Sales [Member] Customer [Axis] First Customers [Member] Second Customers [Member] Accounts Receivable [Member] One Customer [Member] Third Customer [Member] Fourth Customer [Member] Equity Components [Axis] Common Stock Additional Paid-In Capital Accumulated Deficit Treasury Stock Document and Entity Information: Entity Registrant Name Document Type Document Period End Date Trading Symbol Amendment Flag Entity Central Index Key Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Entity Filer Category Entity's Reporting Status Current Entity Emerging Growth Company Entity Small Business Entity Voluntary Filers Entity Well-known Seasoned Issuer Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash Accounts receivable Inventory Total current assets Other assets Property and equipment, net Intangilbe assets, net Deposits Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable and accrued expenses Accrued interest on notes payable Amounts due to related parties Deferred revenue Notes payable Convertible notes payable, net Derivative liability Total current liabilities Stockholders' equity Preferred stock, $.001 par value; authorized - 100,000,000 shares; No shares issued and outstanding Common stock, $.001 par value; authorized - 800,000,000 shares; 361,577,519 and 214,859,994 shares issued and 351,577,519 and 204,859,994 shares outstanding (net of treasury shares) as of March 31, 2019 and December 31, 2018, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity before Treasury stock Less: Treasury stock; 10,000,000 shares, at cost Total stockholders' equity Liabilities and equity Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock Income Statement [Abstract] Sales Cost of Sales Gross profit (loss) Operating Expenses General and Administrative Expense Amortization Total operating expenses Loss from operations Other income (expenses) Change in fair value of derivative liability Loss on extinguishment of debt Interest Expense Total other income (expenses) Net loss Basic and fully diluted loss per common share: Net loss per common share Weighted average common shares outstanding - basic and fully diluted Statement [Table] Statement [Line Items] Stockholders' Equity, beginning of period, Value Stockholders' Equity, beginning of period, Shares Common stock issued for cash, Value Common stock issued for cash, Shares Compensation for vested stock options Notes payable and accrued interest converted to common stock, Value Notes payable and accrued interest converted to common stock, Shares Net loss Stockholders' Equity, end of period, Value Stockholders' Equity, end of period, Shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities Depreciation Non cash interest expense Stock-based compensation expense Loss on extinguishment of debt Change in fair value of derivative liability Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other current assets Accounts payable and accrued expenses Deferred revenue NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from issuance of convertible debt Proceeds from sale of common stock Proceeds from related party loans Repayments of related party loans NET CASH PROVIDED BY FINANCING ACTIVITIES NET INCREASE IN CASH CASH - BEGINNING OF PERIOD CASH - END OF PERIOD SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Cash paid during the period for Interest Non-cash investing and financing activities: Debt discount related to derivative liability Notes payable converted to common stock Common stock issued in payment of accrued interest Disclosure Text Block [Abstract] Note 1 - Organization and Basis of Presentation Note 2 - Summary of Significant Accounting Policies Note 3 - Going Concern Note 4 - Property and Equipment Note 5 - Intangible Assets Note 6 - Earnings (Loss) Per Common Share Note 7 - Stock Based Compensation Note 8 - Convertible Debt Notes to Financial Statements Note 9 - Derivative Liability Note 10 - Note Payable Note 11 - Stock Transactions Note 12 - Income Taxes Note 13 - Concentrations and Credit Risk Note 14 - Related Party Transactions Note 15 - Commitments and Contingencies Note 16 - Subsequent Events Policy Text Block [Abstract] Principles of Consolidation Use of Estimates in the Preparation of Financial Statements Fair Value Measurements Convertible Instruments Revenue Recognition Advertising Costs Cash and Cash Equivalents Accounts Receivable Inventory Property and equipment and depreciation Amortization Long-Lived Assets Deferred Revenue Stock-Based Compensation Income Taxes Recent Accounting Pronouncements Fair value assets and liabilities measured on recurring basis Schedule of estimated lives of respective assets Schedule of estimated lives of the respective assets Schedule of property, plant and equipment Schedule of intangible assets Computation of diluted net income (loss) per share Schedule of stock option activities Schedule of stock options outstanding Schedule of Warrants, Activity Schedule of Outstanding Warrants Schedule of convertible notes payable Schedule of Valuation Assumptions Schedule of Future Minimum Rental Payments for Operating Leases Liabilities: Balance of derivative liabilities - beginning of year Issued Converted Change in fair value of derivative liabilities Balance of derivative liabilities - end of period Office equipment useful life Intangible assets useful life Intangible assets useful life Advertising costs Deferred revenue Working capital deficit Office equipment and fixtures Less: accumulated depreciation Property, Plant and Equipment, Net Depreciation expense Intangible Assets, Gross Less: Accumulated amortization Intangible Assets, Net Amortization expense Total shares excluded from calculation Options, Outstanding, Beginning Balance Options, Outstanding, Beginning Balance, Weighted Average Exercise Price Options, Outstanding, Beginning Balance, Weighted Average Grant-Date Fair Value Options, Outstanding, Beginning Weighted Average Remaining Contractual Term Options, Expired Options, Expired , Weighted Average Exercise Price Options, Granted Options, Granted, Weighted Average Exercise Price Options, Canceled Options, Canceled, Weighted Average Exercise Price Options, Outstanding, Ending Balance Options, Outstanding, Ending Balance, Weighted Average Exercise Price Options, Outstanding, Ending Balance, Weighted Average Grant-Date Fair Value Options, Outstanding, Ending Weighted Average Remaining Contractual Term Class of Warrant or Right [Axis] Exercise Price Range [Axis] Issued Date Number of Outstanding Number Exercisable Exercise price Options outstanding Expiration Date Text Block [Abstract] Warrants, Outstanding, Beginning Balance Warrants, Outstanding, Beginning Balance, Weighted Average Exercise Price Warrants, Outstanding, Beginning Balance, Weighted Average Grant-Date Fair Value Warrants, Outstanding, Beginning Balance, Weighted Average Remaining Contractual Life Warrants, Granted Warrants, Granted, Weighted Average Exercise Price Warrants, Outstanding, Ending Balance Warrants, Outstanding, Ending Balance, Weighted Average Exercise Price Warrants, Outstanding, Ending Balance, Weighted Average Grant-Date Fair Value Warrants, Outstanding, Beginning Balance, Weighted Average Remaining Contractual Life Issued Date Number of Outstanding Number Exercisable Exercise price Expiration Date Total face value of notes Less: Discount Balance Interest expense on the convertible notes Interest expense on the convertible debentures Debt Conversion, Converted Instrument, Amount Debt Conversion, Converted Instrument, Shares Issued Interest rate Maturity date Convertible note Annual dividend yield Expected life (years) Risk-free interest rate Expected volatility Notes payable from discontinued operations Related Party [Axis] Concentration percentage FDIC Amounts due to related parties Commitments and Contingencies Disclosure [Abstract] 2019 Rent expense Term Base Salary Represents the textual narrative disclosure of Note12 - Convertible Note Payable, during the indicated time period. Derivative liabilities converted. Derivative liabilities issued. Interest expense on convertible debentures. Represents the textual narrative disclosure of Note 6 - Intangible Assets, during the indicated time period. Number of notes payable and accrued interest converted to common stock. Amount paid notes payable and accrued interest converted to common stock. Option issued date. Options outstanding ending weighted average remaining contractual term. Options outstanding expiration date. Share based compensation arrangement by share based payment award options expired in period. Total amount of stockholders equity deficiency before treasury stock. Warrants granted weighted average exercise price. Warrants outstanding beginning balance weighted average remaining contractual life. Warrants, Outstanding, Weighted Average Exercise Price Working capital deficit. Assets, Current Assets Liabilities TotalStockholdersEquityDeficiencyBeforeTreasuryStock Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses [Default Label] Operating Income (Loss) Interest Expense Other Nonoperating Income (Expense) Net Income (Loss) Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable Increase (Decrease) in Deferred Revenue Repayments of Related Party Debt Cash and Cash Equivalents, Period Increase (Decrease) Cash [Default Label] Inventory, Policy [Policy Text Block] Document and Entity Information: [Default Label] Derivative Liability IntangibleAssetsUsefulLife Disposal Group, Including Discontinued Operation, Deferred Revenue Furniture and Fixtures, Gross Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Warrants, Outstanding, Beginning Balance, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value WarrantsOutstandingBeginningBalanceWeightedAverageRemainingContractualLife Debt Instrument, Issuance Date Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Class of Warrant or Right, Exercise Price of Warrants or Rights Due to Related Parties EX-101.PRE 11 igmb-20190331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information
 3 Months Ended
Mar. 31, 2019
shares
Document and Entity Information:  
Entity Registrant Name iGambit, Inc.
Document Type 10-Q
Document Period End Date Mar. 31, 2019
Trading Symbol igmb
Amendment Flag false
Entity Central Index Key 0001479681
Current Fiscal Year End Date --12-31
Entity Common Stock, Shares Outstanding 387,553,890
Entity Filer Category Non-accelerated Filer
Entity's Reporting Status Current Yes
Entity Emerging Growth Company false
Entity Small Business true
Document Fiscal Year Focus 2019
Document Fiscal Period Focus Q1
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash $ 7,036 $ 369
Accounts receivable 10,366 14,871
Inventory 26,988 27,073
Total current assets 44,390 42,313
Other assets    
Property and equipment, net 1,871 2,118
Intangilbe assets, net 2,398,048 2,572,015
Deposits 2,020 2,020
Total Assets 2,446,329 2,618,466
Current liabilities    
Accounts payable and accrued expenses 570,331 480,270
Accrued interest on notes payable 20,939 32,265
Amounts due to related parties 139,753 145,367
Deferred revenue 5,467 9,192
Notes payable 52,500 52,500
Convertible notes payable, net 214,368 377,611
Derivative liability 219,516 288,242
Total current liabilities 1,222,874 1,385,447
Stockholders' equity    
Preferred stock, $.001 par value; authorized - 100,000,000 shares; No shares issued and outstanding 0 0
Common stock, $.001 par value; authorized - 800,000,000 shares; 361,577,519 and 214,859,994 shares issued and 351,577,519 and 204,859,994 shares outstanding (net of treasury shares) as of March 31, 2019 and December 31, 2018, respectively 361,577 214,860
Additional paid-in capital 14,884,059 14,480,973
Accumulated deficit (13,022,181) (12,462,814)
Total stockholders' equity before Treasury stock 2,223,455 2,233,019
Less: Treasury stock; 10,000,000 shares, at cost (1,000,000) (1,000,000)
Total stockholders' equity 1,223,455 1,233,019
Liabilities and equity $ 2,446,329 $ 2,618,466
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Preferred stock, shares authorized 100,000,000 100,000,000
Preferred stock, par value $ .001 $ .001
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ .001 $ .001
Common stock, shares authorized 800,000,000 800,000,000
Common stock, shares issued 361,577,519 214,859,994
Common stock, shares outstanding 351,577,519 204,859,994
Treasury stock 10,000,000 10,000,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Sales $ 5,325 $ 4,192
Cost of Sales 8,207 7,930
Gross profit (loss) (2,882) (3,738)
Operating Expenses    
General and Administrative Expense 190,264 234,264
Amortization 173,967 173,967
Total operating expenses 364,231 408,231
Loss from operations (367,113) (411,969)
Other income (expenses)    
Change in fair value of derivative liability (53,163) (118,101)
Loss on extinguishment of debt (5,838) (63,699)
Interest Expense (133,253) (16,264)
Total other income (expenses) (192,254) (198,064)
Net loss $ (559,367) $ (610,033)
Basic and fully diluted loss per common share:    
Net loss per common share $ 0.00 $ (.01)
Weighted average common shares outstanding - basic and fully diluted 286,206,039 121,245,294
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Treasury Stock
Total
Stockholders' Equity, beginning of period, Value at Dec. 31, 2017 $ 126,196 $ 12,891,348 $ (9,648,569) $ (1,000,000) $ 2,368,975
Stockholders' Equity, beginning of period, Shares at Dec. 31, 2017 126,196,571        
Common stock issued for cash, Value $ 750 14,250 15,000
Common stock issued for cash, Shares 750,000        
Notes payable and accrued interest converted to common stock, Value $ 5,345 342,758 348,103
Notes payable and accrued interest converted to common stock, Shares 5,344,180        
Net loss     (610,033)   (610,033)
Stockholders' Equity, end of period, Value at Mar. 31, 2018 $ 132,291 13,248,356 (10,258,602) (1,000,000) 2,122,045
Stockholders' Equity, end of period, Shares at Mar. 31, 2018 132,290,751        
Stockholders' Equity, beginning of period, Value at Dec. 31, 2018 $ 214,860 14,480,973 (12,462,814) (1,000,000) 1,233,019
Stockholders' Equity, beginning of period, Shares at Dec. 31, 2018 214,859,994        
Compensation for vested stock options 1,025 1,025
Notes payable and accrued interest converted to common stock, Value $ 146,717 402,061 548,778
Notes payable and accrued interest converted to common stock, Shares 146,717,525        
Net loss     (559,367)   (559,367)
Stockholders' Equity, end of period, Value at Mar. 31, 2019 $ 361,577 $ 14,884,059 $ (13,022,181) $ (1,000,000) $ 1,223,455
Stockholders' Equity, end of period, Shares at Mar. 31, 2019 361,577,519        
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (559,367) $ (610,033)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation 247 432
Amortization 173,967 173,967
Non cash interest expense 132,482 15,527
Stock-based compensation expense 1,025 0
Loss on extinguishment of debt 5,838 63,699
Change in fair value of derivative liability 53,163 118,101
Changes in operating assets and liabilities:    
Accounts receivable 4,505 4,733
Inventory 85 0
Prepaid expenses and other current assets 0 16,856
Accounts payable and accrued expenses 90,061 (52,761)
Deferred revenue (3,725) (3,725)
NET CASH USED IN OPERATING ACTIVITIES (101,719) (273,204)
CASH FLOWS FROM INVESTING ACTIVITIES 0 0
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible debt 114,000 309,000
Proceeds from sale of common stock 0 15,000
Proceeds from related party loans 6,386 0
Repayments of related party loans (12,000) 0
NET CASH PROVIDED BY FINANCING ACTIVITIES 108,386 324,000
NET INCREASE IN CASH 6,667 50,796
CASH - BEGINNING OF PERIOD 369 9,449
CASH - END OF PERIOD 7,036 60,245
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Cash paid during the period for Interest 771 737
Non-cash investing and financing activities:    
Debt discount related to derivative liability 206,000 43,249
Notes payable converted to common stock 270,957 102,000
Common stock issued in payment of accrued interest $ 18,177 $ 12,346
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Note 1 - Organization and Basis of Presentation
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 1 - Organization and Basis of Presentation

Note 1 - Organization and Basis of Presentation

 

The consolidated financial statements presented are those of iGambit Inc., (the “Company”) and its wholly-owned subsidiary, HealthDatix, Inc. (“HealthDatix. The Company is a holding company which seeks out acquisitions of operating companies in technology markets. HealthDatix, Inc. is engaged in the business of streamlining the process of managing information in the document-intensive medical field for customers throughout the United States.

 

Interim Financial Statements

 

The following (a) condensed consolidated balance sheet as of December 31, 2018, which has been derived from audited financial statements, and (b) the unaudited condensed consolidated interim financial statements of the Company have been prepared in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2019 are not necessarily indicative of results that may be expected for the year ending December 31, 2019. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2018 included in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on April 16, 2019.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Note 2 - Summary of Significant Accounting Policies
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 2 - Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.  All intercompany accounts and transactions have been eliminated.

 

Use of Estimates in the Preparation of Financial Statements

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. 

 

Fair Value Measurements

 

The Company adopted the provisions of ASC Topic 820, Fair Value Measurements and Disclosures, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.

 

The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of our short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.

 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

 

Level 1 – quoted prices in active markets for identical assets or liabilities

 

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

 

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

 

The estimated fair value of the derivative liability was calculated using the Black-Scholes option pricing model. The Company uses Level 3 inputs to value its derivative liabilities. The following table provides a reconciliation of the beginning and ending balances for the major classes of assets and liabilities measured at fair value using significant unobservable inputs (Level 3) and reflects gains and losses for the three months ended March 31, 2019 and 2018.

 

    2019   2018
Liabilities:        
Balance of derivative liabilities - beginning of period   $ 288,242     $ 66,059  
Issued     273,450       43,249  
Converted     (395,339 )     (227,409 )
Change in fair value recognized in operations     53,163       118,101  
Balance of derivative liabilities - end of period   $ 219,516     $ —    

 

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.

 

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of is’ customers. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the three months ended March 31, 2019 and 2018.

 

iGambit is a holding company and has no sources of revenue.

 

HealthDatix’s revenues are derived primarily from its Software as a Service (SaaS) offerings that are rendered to healthcare providers.  HealthDatix recognizes revenues when the products or services have been provided or delivered, the fees charged are fixed or determinable, HealthDatix and its customers understand the specific nature and terms of the agreed upon transactions, and collectability is reasonably assured.

 

Advertising Costs

 

The Company expenses advertising costs as incurred. There were no advertising costs charged to operations for the three months ended March 31, 2019 and 2018, respectively.

 

Cash and Cash Equivalents

 

For purposes of reporting cash flows, cash and cash equivalents include checking and money market accounts and any highly liquid debt instruments purchased with a maturity of three months or less.

 

Accounts Receivable

 

The Company analyzes the collectability of accounts receivable from continuing operations each accounting period and adjusts its allowance for doubtful accounts accordingly.  A considerable amount of judgment is required in assessing the realization of accounts receivables, including the creditworthiness of each customer, current and historical collection history and the related aging of past due balances.  The Company evaluates specific accounts when it becomes aware of information indicating that a customer may not be able to meet its financial obligations due to deterioration of its financial condition, lower credit ratings, bankruptcy or other factors affecting the ability to render payment.

 

Inventory

 

Inventory consisting of finished products is stated at the lower of cost or net realizable value.

 

Property and equipment and depreciation

 

Property and equipment are stated at cost. Maintenance and repairs are charged to expense when incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income. Depreciation for both financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:

 

Office equipment and fixtures     5 - 7 years  
Computer hardware     5 years  
Computer software     3 years  
Development equipment     5 years  

 

Amortization

Intangible assets are amortized using the straight line method over the estimated lives of the respective assets as follows:

 

Software     5 years  
Technology license     5 years  
Purchased in process R&D     Indefinite  
Customer contracts     10 years  

 

Long-Lived Assets

 

The Company assesses the valuation of components of its property and equipment and other long-lived assets whenever events or circumstances dictate that the carrying value might not be recoverable. The Company bases its evaluation on indicators such as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements and other external market conditions or factors that may be present. If such factors indicate that the carrying amount of an asset or asset group may not be recoverable, the Company determines whether an impairment has occurred by analyzing an estimate of undiscounted future cash flows at the lowest level for which identifiable cash flows exist. If the estimate of undiscounted cash flows during the estimated useful life of the asset is less than the carrying value of the asset, the Company recognizes a loss for the difference between the carrying value of the asset and its estimated fair value, generally measured by the present value of the estimated cash flows.

 

Deferred Revenue

 

Deposits from customers are not recognized as revenues, but as liabilities, until the following conditions are met: revenues are realized when cash or claims to cash (receivable) are received in exchange for goods or services or when assets received in such exchange are readily convertible to cash or claim to cash or when such goods/services are transferred. When such income item is earned, the related revenue item is recognized, and the deferred revenue is reduced. To the extent revenues are generated from the Company’s support and maintenance services, the Company recognizes such revenues when services are completed and billed. The Company has received deposits from its various customers that have been recorded as deferred revenue and presented as current liabilities in the amount of $5,467 and $9,192 as of March 31, 2019 and December 31, 2018, respectively.

 

Stock-Based Compensation

 

The Company accounts for its stock-based awards granted under its employee compensation plan in accordance with ASC Topic No. 718-20, Awards Classified as Equity, which requires the measurement of compensation expense for all share-based compensation granted to employees and non-employee directors at fair value on the date of grant and recognition of compensation expense over the related service period for awards expected to vest.  The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock options and warrants. The Black-Scholes option pricing model requires the input of highly subjective assumptions including the expected stock price volatility of the Company’s common stock, the risk free interest rate at the date of grant, the expected vesting term of the grant, expected dividends, and an assumption related to forfeitures of such grants.  Changes in these subjective input assumptions can materially affect the fair value estimate of the Company’s stock options and warrants.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic No. 740, Income Taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.

 

The Company applies the provisions of ASC Topic No. 740 for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the Company’s financial statements. In accordance with this provision, tax positions must meet a more-likely-than-not recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position.

 

Recent Accounting Pronouncements

 

We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Note 3 - Going Concern
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 3 - Going Concern

Note 3 – Going Concern

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.  The Company has an accumulated deficit of $13,022,181, and a working capital deficit of $1,178,484 at March 31, 2019. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time.  The Company’s continuation as a going concern is dependent upon its ability to obtain necessary equity financing and ultimately from generating revenues from its newly acquired subsidiary to continue operations. The Company expects that working capital requirements will continue to be funded through a combination of its existing funds and further issuances of securities. Working capital requirements are expected to increase in line with the growth of the business. Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund operations over the next twelve months. The Company has no lines of credit or other bank financing arrangements. The Company has financed operations to date through the proceeds of a private placement of equity and debt instruments.  In connection with the Company’s business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) developmental expenses associated with a start-up business and (ii) marketing expenses. The Company intends to finance these expenses with further issuances of securities, and debt issuances. Thereafter, the Company expects it will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to current stockholders. Further, such securities might have rights, preferences or privileges senior to common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict business operations.

 

The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Note 4 - Property and Equipment
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 4 - Property and Equipment

Note 4 – Property and Equipment

 

Property and equipment are carried at cost and consist of the following at March 31, 2019 and December 31, 2018:

 

    2019   2018
Office equipment and fixtures   $ 10,964     $ 10,964  
Less: Accumulated depreciation     9,093       8,846  
    $ 1,871     $ 2,118  

 

Depreciation expense of $247 and $432 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Note 5 - Intangible Assets
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 5 - Intangible Assets

Note 5 – Intangible Assets

 

Intangible assets from the acquisitions of HealthDatix and ECSL consist of the following at March 31, 2019 and December 31, 2018:

 

    2019   2018   Life
Software   $ 156,925     $ 156,925       5 years  
Customer contracts     644,846       644,846       10 years  
FDA 510K clearance     1,396,000       1,396,000       5 years  
Technology license     1,000,000       1,000,000       5 years  
In process research and development     604,000       604,000       Indefinite  
      3,801,771       3,801,771          
Less: Accumulated amortization     1,403,723       1,229,756          
    $ 2,398,048     $ 2,572,015          

 

Amortization expense of $173,967 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Note 6 - Earnings (Loss) Per Common Share
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 6 - Earnings (Loss) Per Common Share

Note 6 - Earnings (Loss) Per Common Share

 

The Company calculates net income (loss) per common share in accordance with ASC 260 “Earnings Per Share” (“ASC 260”). Basic and diluted net earnings (loss) per common share was determined by dividing net earnings (loss) applicable to common stockholders by the weighted average number of common shares outstanding during the period. The Company’s potentially dilutive shares, which include outstanding common stock options and common stock warrants, have not been included in the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 as the result would be anti-dilutive.  

 

    Three Months Ended
    March 31,
    2019   2018
Stock options     20,500,000       8,463,000  
Stock warrants     1,875,000       1,150,000  
Total shares excluded from calculation     22,375,000       9,613,000  
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Note 7 - Stock Based Compensation
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 7 - Stock Based Compensation

Note 7 – Stock Based Compensation

 

Options

 

In 2006, the Company adopted the 2006 Long-Term Incentive Plan (the "2006 Plan").   Awards granted under the 2006 Plan have a ten-year term and may be incentive stock options, non-qualified stock options or warrants. The awards are granted at an exercise price equal to the fair market value on the date of grant and generally vest over a three or four year period. The Plan expired on December 31, 2009, therefore as of March 31, 2019, there was no unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2006 plan.

 

The 2006 Plan provided for the granting of options to purchase up to 10,000,000 shares of common stock.  8,146,900 options have been issued under the plan to date of which 7,157,038 have been exercised and 692,962 have expired to date.  There were 296,900 options outstanding under the 2006 Plan on its expiration date of December 31, 2009. All options issued subsequent to this date were not issued pursuant to any plan.

 

Stock option activity during the three months ended March 31, 2019 and 2018 follows:

 

    Options
Outstanding		   Weighted Average Exercise Price  

Weighted Average Grant-Date

Fair Value

  

Weighted Average Remaining Contractual Life

(Years)

Options outstanding at December 31, 2017     8,463,000     $ 0.07     $ 0.07       7.41  
No option activity     —         —         —            
Options outstanding at  March 31, 2018     8,463,000     $ 0.07       0.07       7.16  
Options outstanding at  December 31, 2018     20,500,000       0.03       0.03       7.52  
No option activity     —         —         —            
Options outstanding at  March 31, 2019     20,500,000     $ 0.03     $ 0.03       7.27  

 

Options outstanding at March 31, 2019 consist of:

 

Date Issued  

Number

Outstanding

  

Number

Exercisable

  

Exercise

Price

  

Expiration

Date

June 6, 2014     250,000       250,000     $ 0.05     June 6, 2019
March 24, 2015     200,000       200,000     $ 0.01     March 24, 2020
April 6, 2017     600,000       600,000     $ 0.03     April 6, 2027
June 6, 2017     700,000       700,000     $ 0.07     June 6, 2022
June 6, 2017     6,500,000       6,500,000     $ 0.07     June 6, 2027
November 1, 2018     12,250,000       12,250,000     $ 0.01     November 1, 2028
Total     20,500,000       20,500,000              

 

 

Warrants

 

In addition to our 2006 Long Term Incentive Plan, we have issued and outstanding compensatory warrants to two consultants entitling the holders to purchase a total of 275,000 shares of our common stock at an average exercise price of $0.94 per share. Warrants to purchase 25,000 shares of common stock vest upon 6 months after the Company engages in an IPO, have an exercise price of $3.00 per share, and expire 2 years after the Company engages in an IPO. Warrants to purchase 250,000 shares of common stock vest 100,000 shares on issuance (June 1, 2009), and 50,000 shares on each of the following three anniversaries of the date of issuance, have exercise prices ranging from $0.50 per share to $1.15 per share, and expire on June 1, 2019. The issuance of the compensatory warrants was not submitted to our shareholders for their approval.

Warrant activity during the three months ended March 31, 2019 and 2018 follows:

 

    Warrants
Outstanding		   Weighted Average Exercise Price   Weighted Average Grant-Date Fair Value  

Weighted Average Remaining Contractual Life

(Years)

Warrants outstanding at December 31, 2017     400,000     $ 0.62     $ 0.10       3.27  
Warrant granted     750,000       0.05       —            
Warrants outstanding at March 31, 2018     1,150,000     $ 0.21     $ 0.10       3.64  
Warrants outstanding at December 31, 2018     1,875,000     $ 0.12     $ 0.12       3.24  
No warrant activity     —         —         —            
Warrants outstanding at March 31, 2019     1,875,000     $ 0.12     $ 0.12       3.00  

 

Warrants outstanding at March 31, 2019 consist of:

 

Dater Issued  

Number

Outstanding

  

Number

Exercisable

  

Exercise

Price

  

Expiration

Date

June 1, 2009     100,000       100,000     $ 0.50     June 1, 2019
June 1, 2009     50,000       50,000     $ 0.65     June 1, 2019
June 1, 2009     50,000       50,000     $ 0.85     June 1, 2019
June 1, 2009     50,000       50,000     $ 1.15     June 1, 2019
January 1, 2017     50,000       50,000     $ 0.25     October 10, 2021
January 1, 2017     50,000       50,000     $ 0.50     November 7, 2021
January 5, 2017     25,000       25,000     $ 0.50     January 5, 2022
February 5, 2018     750,000       750,000     $ 0.05     February 5, 2023
April 27, 2018     750,000       750,000     $ 0.05     April 27, 2023
Total     1,875,000       1,875,000              
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Note 8 - Convertible Debt
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 8 - Convertible Debt

Note 8 – Convertible Debt

 

Convertible Notes Payable

 

On January 10, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $240,000, convertible into shares of the Company’s common stock, and includes a back-ended note with principal of $120,000 that was funded on July 10, 2018. The back-ended Note, including accrued interest is due July 10, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 15 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted $66,000 of the principal balance and accrued interest of $4,995 to 44,490,002 shares of common stock. The balance of the note was $100,000 on March 31, 2019.

 

On March 6, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $126,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due March 6, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the lowest trading price during the 20 trading day period ending on the latest complete trading day prior to and including the conversion date. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $60,000 and accrued interest of $4,342 to 35,446,300 shares of common stock.

 

On May 3, 2018, the Company entered into a Convertible Promissory Note pursuant to which the Company borrowed in the aggregate principal amount of $83,500. The convertible note is due 12 months after issuance and bears interest at a rate of 8%. The Note is convertible into shares of common stock of the Company 180 days following the date of funding and thereafter. The conversion price shall be subject to a discount of 35% applied to the average of the three lowest closing bid prices of the Common Stock during the prior twenty (20) trading day period. The Investor will be limited to convert no more than 4.99% of the issued and outstanding Common Stock at the time of conversion at any one time. At any time during the period beginning on the date of the Note and ending on the date which is 180 days thereafter, the Company may repay the Note by paying an amount equal to the then outstanding amount multiplied by 130%. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $53,957 and accrued interest of $4,600 to 25,674,344 shares of common stock.

 

On June 25, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $53,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due April 15, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted the remaining principal balance of $38,000 and accrued interest of $2,120 to 14,859,260 shares of common stock.

 

On August 13, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $53,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due May 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date. During the three months ended March 31, 2019, the noteholder converted the principal balance of the note and accrued interest of $2,120 to 26,247,619 shares of common stock.

 

On September 17, 2018, the Company issued an 8% convertible note in the aggregate principal amount of $33,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due June 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

On January 3, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due October 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

On February 15, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due November 30, 2019 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

On March 29, 2019, the Company issued an 8% convertible note in the aggregate principal amount of $38,000, convertible into shares of the Company’s common stock. The Note, including accrued interest is due February 15, 2020 and is convertible any time after 180 days at the option of the holder into shares of the Company’s common stock at 65% of the average stock price of the lowest 3 closing bid prices during the 10 trading day period ending on the latest complete trading day prior to the conversion date.

 

The Company recorded a debt discount related to identified embedded derivatives relating to conversion features and a reset provisions (see Note 9) based fair values as of the inception date of the Notes. The calculated debt discount equaled the face of the 8% note dated January 10, 2018 and is being amortized and revalued over the term of the note. The calculated debt discount equaled the face of the 8% note dated March 6, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated May 3, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated June 25, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated August 13, 2018 and was amortized through the date the convertible debt was fully extinguished. The calculated debt discount equaled the face of the 8% note dated September 17, 2018 and is being amortized and revalued over the term of the note. Interest expense on the convertible notes of $130,362 and $14,878 was recorded for the three months ended March 31, 2019 and 2018, respectively.

 

The Company issued convertible debentures in the amount of $75,000 to three individuals. The debentures are convertible into 75,000 shares of common stock for up to 5 years, at the holders’ option, at an exercise price of $.50 and $.25, respectively. The debentures mature on the earlier of the closing of a subsequent financing event by the Company resulting in gross proceeds of at least $10,000,000 or three years from the date of issuance. The debentures bear interest at a rate of 10%. A beneficial conversion feature was not recorded as the fair market value of the Company’s common stock was less than the exercise prices at the dates of issuance and through the end of the year. Interest expense on the convertible debentures of $2,120 and $1,829 was recorded for the three months ended March 31, 2019 and 2018, respectively.

 

Convertible notes payable at March 31, 2019 and December 31, 2018 are summarized as follows:

 

    2019   2018
Total face value of notes   $ 322,000     $ 478,957  
Less: Discount     107,632       101,346  
Balance   $ 214,368     $ 377,611  
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Note 9 - Derivative Liability
 3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Note 9 - Derivative Liability

Note 9 – Derivative Liability

 

The Company has determined that the conversion feature embedded in the convertible notes described in Note 8 contain a potential variable conversion amount which constitutes a derivative which has been bifurcated from the note and recorded as a derivative liability at fair value, with a corresponding discount recorded to the associated debt. The excess of the derivative value over the face amount of the note is recorded immediately to interest expense at inception. The Company used the Binomial Option Pricing model to value the conversion features.

 

The Company used Level 3 inputs for its valuation methodology for the conversion option liability in determining the fair value using a Black-Scholes option-pricing model with the following assumption inputs:

 

      March 31,       December 31,  
      2019       2018  
Annual dividend yield     —         —    
Expected life (years)      0.78 - 1.0        0.77 - 1.0  
Risk-free interest rate      2.44% - 2.52%        2.07% - 2.57%  
Expected volatility      274% - 280%        257% - 293%  

 

Based upon ASC 840-15-25 (EITF Issue 00-19, paragraph 11) the Company has adopted a sequencing approach regarding the application of ASC 815-40 to its outstanding convertible notes. Pursuant to the sequencing approach, the Company evaluates its contracts based upon earliest issuance date.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Note 10 - Note Payable
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 10 - Note Payable

Note 10 – Notes Payable

 

Notes payable at March 31, 2019 and December 31, 2018 consists of loans to HealthDatix from 3 individuals totaling $52,500. The loans do not bear interest and there are no specific terms for repayment.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Note 11 - Stock Transactions
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 11 - Stock Transactions

Note 11 – Stock Transactions

 

Designation of Preferred Stock

 

On August 2, 2018, the Company filed a Certificate of Designation with the Delaware Division of Corporations whereby the Company designated a Series A Preferred Stock and issued 1,000 shares to the Company’s CEO. The holders of Series A Preferred Stock will have voting rights, when combined with their existing holdings of the Company’s common stock, that entitle them to have an aggregate of 51% of the votes eligible to be cast by all stockholders with respect to all matters brought before a vote of the stockholders of the Company.

 

Common Stock Issued

 

On August 8, 2018, the Board unanimously approved an amendment to the Company’s Articles of Incorporation to increase the number of shares of Common Stock which the Company is authorized to issue from Four hundred million (400,000,000) to Eight Hundred Million (800,000,000) shares of Common Stock, $0.001 par value per share.

 

In connection with the convertible notes payable (see Note 8 above) the noteholders converted $270,957 of principal balance and $18,177 of accrued interest to 146,717,525 shares of common stock during the three months ended March 31, 2019. The stock issued was determined based on the terms of the convertible notes.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Note 12 - Income Taxes
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 12 - Income Taxes

Note 12 - Income Taxes

 

A full valuation allowance was recorded against the Company’s net deferred tax assets. A valuation allowance must be established if it is more likely than not that the deferred tax assets will not be realized. This assessment is based upon consideration of available positive and negative evidence, which includes, among other things, the Company’s most recent results of operations and expected future profitability. Based on the Company’s cumulative losses in recent years, a full valuation allowance against the Company’s deferred tax assets has been established as Management believes that the Company will not realize the benefit of those deferred tax assets.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Note 13 - Concentrations and Credit Risk
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 13 - Concentrations and Credit Risk

Note 13 – Concentrations and Credit Risk

 

Sales and Accounts Receivable

 

HealthDatix had sales to three customers which accounted for approximately 24%, 17%, and 17%, respectively of HealthDatix’s total sales for the three months ended March 31, 2019. One customer accounted for approximately 96% of accounts receivable at March 31, 2019.

 

HealthDatix had sales to four customers which accounted for approximately 30%, 21%, 21%, and 19%, respectively of HealthDatix’s total sales for the three months ended March 31, 2018. One customer accounted for 100% of accounts receivable at March 31, 2018.

 

Cash

 

Cash is maintained at a major financial institution. Accounts held at U.S. financial institutions are insured by the FDIC up to $250,000. Cash balances could exceed insured amounts at any given time, however, the Company has not experienced any such losses. The Company did not have any interest-bearing accounts at March 31, 2019 and December 31, 2018, respectively.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Note 14 - Related Party Transactions
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 14 - Related Party Transactions

Note 14 - Related Party Transactions

 

Amounts Due to Related Parties

 

Amounts due to related parties with balances of $139,753 and $145,367 at March 31, 2019 and December 31, 2018, respectively, do not bear interest and are payable on demand. The Company’s former subsidiary, Arcmail owed amounts on a credit card that is guaranteed by the husband of the Company’s Executive Vice President, who was held personally responsible by the credit card company for the unpaid balance.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Note 15 - Commitments and Contingencies
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 15 - Commitments and Contingencies

Note 15 – Commitments and Contingencies

 

Lease Commitment

 

The Company is obligated under an operating lease for its premises in Smithtown, New York that expires on May 31, 2019. The lease was not renewed and the officers of the Company will provide office space to the Company at no charge.

 

Total future minimum annual lease payments under the lease for the years ending December 31 are as follows:

 

2019   $ 3,380  

 

Rent expense of $7,728 and $7,048 was charged to operations for the three months ended March 31, 2019 and 2018, respectively.

 

Employment Arrangements With Executive Officers

 

Effective April 1, 2017, in connection with the acquisition of HealthDatix Inc., the Company entered into employment agreements with Jerry Robinson, MaryJo Robinson, and Kathleen Shepherd each under a three-year term at a base salary of $75,000 per year, bonuses based upon objectives set by the Company, and participation in all benefit programs generally made available to HealthDatix employees. The employment agreements restrict the executive officers from engaging in certain competitive activities for the greater of 60 months from the date of the agreements or two years following the termination of their respective employment.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Note 16 - Subsequent Events
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Note 16 - Subsequent Events

Note 16 – Subsequent Events

 

Common Stock Issued

 

Subsequent to the end of the period through the date of the report, a noteholder converted $55,232 of principal and $1,691 of accrued interest to 35,966,371 shares of the Company’s common stock.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Note 2 - Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2019
Policy Text Block [Abstract]  
Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.  All intercompany accounts and transactions have been eliminated.
Use of Estimates in the Preparation of Financial Statements

Use of Estimates in the Preparation of Financial Statements

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.
Fair Value Measurements

Fair Value Measurements

 

The Company adopted the provisions of ASC Topic 820, Fair Value Measurements and Disclosures, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.

 

The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of our short- and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.

 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

 

Level 1 – quoted prices in active markets for identical assets or liabilities

 

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

 

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

 

The estimated fair value of the derivative liability was calculated using the Black-Scholes option pricing model. The Company uses Level 3 inputs to value its derivative liabilities. The following table provides a reconciliation of the beginning and ending balances for the major classes of assets and liabilities measured at fair value using significant unobservable inputs (Level 3) and reflects gains and losses for the three months ended March 31, 2019 and 2018.

 

    2019   2018
Liabilities:        
Balance of derivative liabilities - beginning of period   $ 288,242     $ 66,059  
Issued     273,450       43,249  
Converted     (395,339 )     (227,409 )
Change in fair value recognized in operations     53,163       118,101  
Balance of derivative liabilities - end of period   $ 219,516     $ —    
Convertible Instruments

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

The Company accounts for the conversion of convertible debt when a conversion option has been bifurcated using the general extinguishment standards. The debt and equity linked derivatives are removed at their carrying amounts and the shares issued are measured at their then-current fair value, with any difference recorded as a gain or loss on extinguishment of the two separate accounting liabilities.
Revenue Recognition

Revenue Recognition

 

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured. The Company has no outstanding contracts with any of is’ customers. There was no impact on the Company’s financial statements as a result of adopting Topic 606 for the three months ended March 31, 2019 and 2018.

        

iGambit is a holding company and has no sources of revenue.

 

HealthDatix’s revenues are derived primarily from its Software as a Service (SaaS) offerings that are rendered to healthcare providers.  HealthDatix recognizes revenues when the products or services have been provided or delivered, the fees charged are fixed or determinable, HealthDatix and its customers understand the specific nature and terms of the agreed upon transactions, and collectability is reasonably assured.
Advertising Costs

Advertising Costs

 

The Company expenses advertising costs as incurred. There were no advertising costs charged to operations for the three months ended March 31, 2019 and 2018, respectively.
Cash and Cash Equivalents

Cash and Cash Equivalents

 

For purposes of reporting cash flows, cash and cash equivalents include checking and money market accounts and any highly liquid debt instruments purchased with a maturity of three months or less.
Accounts Receivable

Accounts Receivable

 

The Company analyzes the collectability of accounts receivable from continuing operations each accounting period and adjusts its allowance for doubtful accounts accordingly.  A considerable amount of judgment is required in assessing the realization of accounts receivables, including the creditworthiness of each customer, current and historical collection history and the related aging of past due balances.  The Company evaluates specific accounts when it becomes aware of information indicating that a customer may not be able to meet its financial obligations due to deterioration of its financial condition, lower credit ratings, bankruptcy or other factors affecting the ability to render payment.
Inventory

Inventory

 

Inventory consisting of finished products is stated at the lower of cost or net realizable value.
Property and equipment and depreciation

Property and equipment and depreciation

 

Property and equipment are stated at cost. Maintenance and repairs are charged to expense when incurred. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts and any gain or loss is credited or charged to income. Depreciation for both financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:

 

Office equipment and fixtures     5 - 7 years  
Computer hardware     5 years  
Computer software     3 years  
Development equipment     5 years  
Amortization

Amortization

Intangible assets are amortized using the straight line method over the estimated lives of the respective assets as follows:

 

Software     5 years  
Technology license     5 years  
Purchased in process R&D     Indefinite  
Customer contracts     10 years  
Long-Lived Assets

Long-Lived Assets

 

The Company assesses the valuation of components of its property and equipment and other long-lived assets whenever events or circumstances dictate that the carrying value might not be recoverable. The Company bases its evaluation on indicators such as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements and other external market conditions or factors that may be present. If such factors indicate that the carrying amount of an asset or asset group may not be recoverable, the Company determines whether an impairment has occurred by analyzing an estimate of undiscounted future cash flows at the lowest level for which identifiable cash flows exist. If the estimate of undiscounted cash flows during the estimated useful life of the asset is less than the carrying value of the asset, the Company recognizes a loss for the difference between the carrying value of the asset and its estimated fair value, generally measured by the present value of the estimated cash flows.
Deferred Revenue

Deferred Revenue

 

Deposits from customers are not recognized as revenues, but as liabilities, until the following conditions are met: revenues are realized when cash or claims to cash (receivable) are received in exchange for goods or services or when assets received in such exchange are readily convertible to cash or claim to cash or when such goods/services are transferred. When such income item is earned, the related revenue item is recognized, and the deferred revenue is reduced. To the extent revenues are generated from the Company’s support and maintenance services, the Company recognizes such revenues when services are completed and billed. The Company has received deposits from its various customers that have been recorded as deferred revenue and presented as current liabilities in the amount of $5,467 and $9,192 as of March 31, 2019 and December 31, 2018, respectively.
Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for its stock-based awards granted under its employee compensation plan in accordance with ASC Topic No. 718-20, Awards Classified as Equity, which requires the measurement of compensation expense for all share-based compensation granted to employees and non-employee directors at fair value on the date of grant and recognition of compensation expense over the related service period for awards expected to vest.  The Company uses the Black-Scholes option pricing model to estimate the fair value of its stock options and warrants. The Black-Scholes option pricing model requires the input of highly subjective assumptions including the expected stock price volatility of the Company’s common stock, the risk free interest rate at the date of grant, the expected vesting term of the grant, expected dividends, and an assumption related to forfeitures of such grants.  Changes in these subjective input assumptions can materially affect the fair value estimate of the Company’s stock options and warrants.
Income Taxes

Income Taxes

 

The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic No. 740, Income Taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.

 

The Company applies the provisions of ASC Topic No. 740 for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the Company’s financial statements. In accordance with this provision, tax positions must meet a more-likely-than-not recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

We have reviewed other recent accounting pronouncements and concluded they are either not applicable to the business, or no material effect is expected on the condensed consolidated financial statements as a result of future adoption.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Note 2 - Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Fair value assets and liabilities measured on recurring basis

The following table provides a reconciliation of the beginning and ending balances for the major classes of assets and liabilities measured at fair value using significant unobservable inputs (Level 3) and reflects gains and losses for the three months ended March 31, 2019 and 2018.

 

    2019   2018
Liabilities:        
Balance of derivative liabilities - beginning of period   $ 288,242     $ 66,059  
Issued     273,450       43,249  
Converted     (395,339 )     (227,409 )
Change in fair value recognized in operations     53,163       118,101  
Balance of derivative liabilities - end of period   $ 219,516     $ —    
Schedule of estimated lives of respective assets

Depreciation for both financial reporting and income tax purposes is computed using combinations of the straight line and accelerated methods over the estimated lives of the respective assets as follows:

 

Office equipment and fixtures     5 - 7 years  
Computer hardware     5 years  
Computer software     3 years  
Development equipment     5 years  
Schedule of estimated lives of the respective assets

Intangible assets are amortized using the straight line method over the estimated lives of the respective assets as follows:

 

Software     5 years  
Technology license     5 years  
Purchased in process R&D     Indefinite  
Customer contracts     10 years  
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Note 4 - Property and Equipment (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Schedule of property, plant and equipment

Property and equipment are carried at cost and consist of the following at March 31, 2019 and December 31, 2018:

 

    2019   2018
Office equipment and fixtures   $ 10,964     $ 10,964  
Less: Accumulated depreciation     9,093       8,846  
    $ 1,871     $ 2,118  
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Note 5 - Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Schedule of intangible assets

Intangible assets from the acquisitions of HealthDatix and ECSL consist of the following at March 31, 2019 and December 31, 2018:

 

    2019   2018   Life
Software   $ 156,925     $ 156,925       5 years  
Customer contracts     644,846       644,846       10 years  
FDA 510K clearance     1,396,000       1,396,000       5 years  
Technology license     1,000,000       1,000,000       5 years  
In process research and development     604,000       604,000       Indefinite  
      3,801,771       3,801,771          
Less: Accumulated amortization     1,403,723       1,229,756          
    $ 2,398,048     $ 2,572,015          
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Note 6 - Earnings (Loss) Per Common Share (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Computation of diluted net income (loss) per share

The Company’s potentially dilutive shares, which include outstanding common stock options and common stock warrants, have not been included in the computation of diluted net loss per share for the three months ended March 31, 2019 and 2018 as the result would be anti-dilutive.  

 

    Three Months Ended
    March 31,
    2019   2018
Stock options     20,500,000       8,463,000  
Stock warrants     1,875,000       1,150,000  
Total shares excluded from calculation     22,375,000       9,613,000  
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Note 7 - Stock Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Schedule of stock option activities

Stock option activity during the three months ended March 31, 2019 and 2018 follows:

 

    Options
Outstanding		   Weighted Average Exercise Price  

Weighted Average Grant-Date

Fair Value

  

Weighted Average Remaining Contractual Life

(Years)

Options outstanding at December 31, 2017     8,463,000     $ 0.07     $ 0.07       7.41  
No option activity     —         —         —            
Options outstanding at  March 31, 2018     8,463,000     $ 0.07       0.07       7.16  
Options outstanding at  December 31, 2018     20,500,000       0.03       0.03       7.52  
No option activity     —         —         —            
Options outstanding at  March 31, 2019     20,500,000     $ 0.03     $ 0.03       7.27  
Schedule of stock options outstanding

Options outstanding at March 31, 2019 consist of:

 

Date Issued  

Number

Outstanding

  

Number

Exercisable

  

Exercise

Price

  

Expiration

Date

June 6, 2014     250,000       250,000     $ 0.05     June 6, 2019
March 24, 2015     200,000       200,000     $ 0.01     March 24, 2020
April 6, 2017     600,000       600,000     $ 0.03     April 6, 2027
June 6, 2017     700,000       700,000     $ 0.07     June 6, 2022
June 6, 2017     6,500,000       6,500,000     $ 0.07     June 6, 2027
November 1, 2018     12,250,000       12,250,000     $ 0.01     November 1, 2028
Total     20,500,000       20,500,000              
Schedule of Warrants, Activity

Warrant activity during the three months ended March 31, 2019 and 2018 follows:

 

    Warrants
Outstanding		   Weighted Average Exercise Price   Weighted Average Grant-Date Fair Value  

Weighted Average Remaining Contractual Life

(Years)

Warrants outstanding at December 31, 2017     400,000     $ 0.62     $ 0.10       3.27  
Warrant granted     750,000       0.05       —            
Warrants outstanding at March 31, 2018     1,150,000     $ 0.21     $ 0.10       3.64  
Warrants outstanding at December 31, 2018     1,875,000     $ 0.12     $ 0.12       3.24  
No warrant activity     —         —         —            
Warrants outstanding at March 31, 2019     1,875,000     $ 0.12     $ 0.12       3.00  
Schedule of Outstanding Warrants

Warrants outstanding at March 31, 2019 consist of:

 

Dater Issued  

Number

Outstanding

  

Number

Exercisable

  

Exercise

Price

  

Expiration

Date

June 1, 2009     100,000       100,000     $ 0.50     June 1, 2019
June 1, 2009     50,000       50,000     $ 0.65     June 1, 2019
June 1, 2009     50,000       50,000     $ 0.85     June 1, 2019
June 1, 2009     50,000       50,000     $ 1.15     June 1, 2019
January 1, 2017     50,000       50,000     $ 0.25     October 10, 2021
January 1, 2017     50,000       50,000     $ 0.50     November 7, 2021
January 5, 2017     25,000       25,000     $ 0.50     January 5, 2022
February 5, 2018     750,000       750,000     $ 0.05     February 5, 2023
April 27, 2018     750,000       750,000     $ 0.05     April 27, 2023
Total     1,875,000       1,875,000              
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Note 8 - Convertible Debt (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Schedule of convertible notes payable

Convertible notes payable at March 31, 2019 and December 31, 2018 are summarized as follows:

 

    2019   2018
Total face value of notes   $ 322,000     $ 478,957  
Less: Discount     107,632       101,346  
Balance   $ 214,368     $ 377,611  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Note 9 - Derivative Liability (Tables)
 3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Schedule of Valuation Assumptions

The Company used Level 3 inputs for its valuation methodology for the conversion option liability in determining the fair value using a Black-Scholes option-pricing model with the following assumption inputs:

 

      March 31,       December 31,  
      2019       2018  
Annual dividend yield     —         —    
Expected life (years)      0.78 - 1.0        0.77 - 1.0  
Risk-free interest rate      2.44% - 2.52%        2.07% - 2.57%  
Expected volatility      274% - 280%        257% - 293%  
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Note 15 - Commitments and Contingencies (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure Text Block [Abstract]  
Schedule of Future Minimum Rental Payments for Operating Leases

Total future minimum annual lease payments under the lease for the years ending December 31 are as follows:

 

2019   $ 3,380  
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Note 2 - Summary of Significant Accounting Policies (Details) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Liabilities:    
Balance of derivative liabilities - beginning of year $ 288,242 $ 66,059
Issued 273,450 43,249
Converted (395,339) (227,409)
Change in fair value of derivative liabilities 53,163 118,101
Balance of derivative liabilities - end of period $ 219,516 $ 0
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Note 2 - Summary of Significant Accounting Policies (Details 1)
 3 Months Ended
Mar. 31, 2019
Computer hardware  
Office equipment useful life 5 years
Computer software  
Office equipment useful life 3 years
Development equipment  
Office equipment useful life 5 years
Maximum | Office equipment and fixtures  
Office equipment useful life 7 years
Minimum | Office equipment and fixtures  
Office equipment useful life 5 years
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.1
Note 2 - Summary of Significant Accounting Policies (Details 2)
 3 Months Ended
Mar. 31, 2019
Technology license  
Intangible assets useful life 5 years
Customer contracts  
Intangible assets useful life 10 years
FDA 510K clearance  
Intangible assets useful life 5 years
In process research and development  
Intangible assets useful life Indefinite
Software  
Intangible assets useful life 5 years
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Note 2 - Summary of Significant Accounting Policies (Details Narratives) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Disclosure Text Block [Abstract]      
Advertising costs $ 0 $ 0  
Deferred revenue $ 5,467   $ 9,192
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.19.1
Note 3 - Going Concern (Details Narrative) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Disclosure Text Block [Abstract]    
Accumulated deficit $ (13,022,181) $ (12,462,814)
Working capital deficit $ (1,178,484)  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.1
Note 4 - Property and Equipment (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Disclosure Text Block [Abstract]    
Office equipment and fixtures $ 10,964 $ 10,964
Less: accumulated depreciation 9,093 8,846
Property, Plant and Equipment, Net $ 1,871 $ 2,118
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Note 4 - Property and Equipment (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Disclosure Text Block [Abstract]    
Depreciation expense $ 247 $ 432
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.1
Note 5 - Intangible Assets (Details) - USD ($)
 3 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Intangible Assets, Gross $ 3,801,771 $ 3,801,771
Less: Accumulated amortization 1,403,723 1,229,756
Intangible Assets, Net 2,398,048 2,572,015
Technology license    
Intangible Assets, Gross $ 1,000,000 1,000,000
Intangible assets useful life 5 years  
Customer contracts    
Intangible Assets, Gross $ 644,846 644,846
Intangible assets useful life 10 years  
FDA 510K clearance    
Intangible Assets, Gross $ 1,396,000 1,396,000
Intangible assets useful life 5 years  
In process research and development    
Intangible Assets, Gross $ 604,000 604,000
Intangible assets useful life Indefinite  
Software    
Intangible Assets, Gross $ 156,925 $ 156,925
Intangible assets useful life 5 years  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.19.1
Note 5 - Intangible Assets (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Disclosure Text Block [Abstract]    
Amortization expense $ 173,967 $ 173,967
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Note 6 - Earnings (Loss) Per Common Share (Details) - shares
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Total shares excluded from calculation 22,375,000 9,613,000
Warrant    
Total shares excluded from calculation 1,875,000 1,150,000
Options    
Total shares excluded from calculation 20,500,000 8,463,000
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.19.1
Note 7 - Stock Based Compensation (Details) - $ / shares
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Disclosure Text Block [Abstract]    
Options, Outstanding, Beginning Balance 20,500,000 8,463,000
Options, Outstanding, Beginning Balance, Weighted Average Exercise Price $ 0.03 $ 0.07
Options, Outstanding, Beginning Balance, Weighted Average Grant-Date Fair Value $ 0.03 $ 0.07
Options, Outstanding, Beginning Weighted Average Remaining Contractual Term 7 years 6 months 7 days 7 years 4 months 28 days
Options, Outstanding, Ending Balance 20,500,000 8,463,000
Options, Outstanding, Ending Balance, Weighted Average Exercise Price $ 0.03 $ 0.07
Options, Outstanding, Ending Balance, Weighted Average Grant-Date Fair Value $ 0.03 $ 0.07
Options, Outstanding, Ending Weighted Average Remaining Contractual Term 7 years 3 months 8 days 7 years 1 month 27 days
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.19.1
Note 7 - Stock Based Compensation (Details 1) - $ / shares
 3 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2017
Number of Outstanding 20,500,000 20,500,000 8,463,000 8,463,000
Number Exercisable 20,500,000      
Exercise price $ 0.03 $ 0.03 $ 0.07 $ 0.07
Options Two        
Issued Date Mar. 24, 2015      
Number of Outstanding 200,000      
Number Exercisable 200,000      
Exercise price $ 0.01      
Options outstanding Expiration Date Mar. 24, 2020      
Options Three        
Issued Date Apr. 06, 2017      
Number of Outstanding 600,000      
Number Exercisable 600,000      
Exercise price $ 0.03      
Options outstanding Expiration Date Apr. 06, 2027      
Options Four        
Issued Date Jun. 06, 2017      
Number of Outstanding 700,000      
Number Exercisable 700,000      
Exercise price $ 0.07      
Options outstanding Expiration Date Jun. 06, 2022      
Options Five        
Issued Date Jun. 06, 2017      
Number of Outstanding 6,500,000      
Number Exercisable 6,500,000      
Exercise price $ 0.07      
Options outstanding Expiration Date Jun. 06, 2027      
Options Six        
Issued Date Nov. 01, 2018      
Number of Outstanding 12,250,000      
Number Exercisable 12,250,000      
Exercise price $ 0.01      
Options outstanding Expiration Date Nov. 01, 2028      
Options One        
Issued Date Jun. 06, 2014      
Number of Outstanding 250,000      
Number Exercisable 250,000      
Exercise price $ 0.05      
Options outstanding Expiration Date Jun. 06, 2019      
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Note 7 - Stock Based Compensation (Details 2) - $ / shares
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Text Block [Abstract]    
Warrants, Outstanding, Beginning Balance 1,875,000 400,000
Warrants, Outstanding, Beginning Balance, Weighted Average Exercise Price $ 0.12 $ 0.62
Warrants, Outstanding, Beginning Balance, Weighted Average Grant-Date Fair Value $ 0.12 $ 0.1
Warrants, Outstanding, Beginning Balance, Weighted Average Remaining Contractual Life 3 years 2 months 27 days 3 years 3 months 8 days
Warrants, Outstanding, Ending Balance 1,875,000 1,150,000
Warrants, Outstanding, Ending Balance, Weighted Average Exercise Price $ 0.12 $ 0.21
Warrants, Outstanding, Ending Balance, Weighted Average Grant-Date Fair Value $ 0.12 $ 0.1
Warrants, Outstanding, Beginning Balance, Weighted Average Remaining Contractual Life 3 years 3 years 7 months 21 days
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.19.1
Note 7 - Stock Based Compensation (Details 3)
 3 Months Ended
Mar. 31, 2019
$ / shares
shares
Number of Outstanding 1,875,000
Number Exercisable 1,875,000
Warrants One  
Issued Date Jun. 01, 2009
Number of Outstanding 100,000
Number Exercisable 100,000
Exercise price | $ / shares $ 0.5
Expiration Date Jun. 01, 2019
Warrants Two  
Issued Date Jun. 01, 2009
Number of Outstanding 50,000
Number Exercisable 50,000
Exercise price | $ / shares $ 0.65
Expiration Date Jun. 01, 2019
Warrants Three  
Issued Date Jun. 01, 2009
Number of Outstanding 50,000
Number Exercisable 50,000
Exercise price | $ / shares $ 0.85
Expiration Date Jun. 01, 2019
Warrants Four  
Issued Date Jun. 01, 2009
Number of Outstanding 50,000
Number Exercisable 50,000
Exercise price | $ / shares $ 1.15
Expiration Date Jun. 01, 2019
Warrants Five  
Issued Date Jan. 01, 2017
Number of Outstanding 50,000
Number Exercisable 50,000
Exercise price | $ / shares $ 0.25
Expiration Date Oct. 10, 2021
Warrants Six  
Issued Date Jan. 01, 2017
Number of Outstanding 50,000
Number Exercisable 50,000
Exercise price | $ / shares $ 0.5
Expiration Date Nov. 07, 2021
Warrants Seven  
Issued Date Jan. 05, 2017
Number of Outstanding 25,000
Number Exercisable 25,000
Exercise price | $ / shares $ 0.5
Expiration Date Jan. 05, 2022
Warrants Eight  
Issued Date Feb. 05, 2018
Number of Outstanding 750,000
Number Exercisable 750,000
Exercise price | $ / shares $ 0.05
Expiration Date Feb. 05, 2023
Warrants Nine  
Issued Date Apr. 27, 2018
Number of Outstanding 750,000
Number Exercisable 750,000
Exercise price | $ / shares $ 0.05
Expiration Date Apr. 27, 2023
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Note 8 - Convertible Debt (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Disclosure Text Block [Abstract]    
Total face value of notes $ 322,000 $ 478,957
Less: Discount 107,632 101,346
Balance $ 214,368 $ 377,611
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.19.1
Note 8 - Convertible Debt (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended
Jan. 03, 2019
Aug. 13, 2018
May 03, 2018
Mar. 06, 2018
Jan. 10, 2018
Mar. 29, 2019
Feb. 15, 2019
Sep. 17, 2018
Jun. 25, 2018
Mar. 30, 2017
Mar. 31, 2019
Mar. 31, 2018
Interest expense on the convertible notes                     $ 130,362 $ 14,878
Interest expense on the convertible debentures                     $ 2,120 $ 1,829
Maturity date                     Mar. 31, 2017  
ConvertibleNoteTwelveMember                        
Debt Conversion, Converted Instrument, Amount $ 38,000                      
Interest rate 8.00%                      
Maturity date Oct. 30, 2019                      
ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Shares Issued                     25,674,344  
ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Shares Issued                     35,446,300  
ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Shares Issued                     44,490,002  
Convertible note                     $ 100,000  
ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Shares Issued                     26,247,619  
ConvertibleNoteThirteenMember                        
Debt Conversion, Converted Instrument, Amount             $ 38,000          
Interest rate             8.00%          
Maturity date             Nov. 30, 2019          
ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Shares Issued                     14,859,260  
ConvertibleNoteFourteenMember                        
Debt Conversion, Converted Instrument, Amount           $ 38,000            
Interest rate           8.00%            
Maturity date           Feb. 15, 2020            
Noteholder                        
Debt Conversion, Converted Instrument, Shares Issued                     146,717,525  
Principal | ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Amount     $ 83,500               $ 53,957  
Interest rate     8.00%                  
Maturity date     May 03, 2019                  
Principal | ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Amount       $ 126,000             60,000  
Interest rate       8.00%                
Maturity date       Mar. 06, 2019                
Principal | ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Amount         $ 240,000           66,000  
Interest rate         8.00%              
Maturity date         Jul. 10, 2018              
Principal | ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Amount   $ 53,000                 53,000  
Interest rate   8.00%                    
Maturity date   May 30, 2019                    
Principal | ConvertibleNoteElevenMember                        
Debt Conversion, Converted Instrument, Amount               $ 33,000        
Interest rate               8.00%        
Maturity date               Jun. 30, 2019        
Principal | ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Amount                 $ 53,000   38,000  
Interest rate                 8.00%      
Maturity date                 Apr. 15, 2019      
Principal | 8% Convertible Note                        
Debt Conversion, Converted Instrument, Amount                   $ 75,000    
Interest rate                   8.00%    
Maturity date                   Jun. 25, 2018    
Principal | Noteholder                        
Debt Conversion, Converted Instrument, Amount                     270,957  
Accrued interest | ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Amount                     4,600  
Accrued interest | ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Amount                     4,342  
Accrued interest | ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Amount                     4,995  
Accrued interest | ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Amount                     2,120  
Accrued interest | ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Amount                     2,120  
Accrued interest | Noteholder                        
Debt Conversion, Converted Instrument, Amount                     $ 18,177  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.19.1
Note 9 - Derivative Liability (Details)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Annual dividend yield 0.00% 0.00%
Maximum    
Expected life (years) 1 year 1 year
Risk-free interest rate 2.52% 2.57%
Expected volatility 280.00% 293.00%
Minimum    
Expected life (years) 9 months 11 days 9 months 7 days
Risk-free interest rate 2.44% 2.07%
Expected volatility 274.00% 257.00%
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.19.1
Note 10 - Note Payable (Details Narratives) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Disclosure Text Block [Abstract]    
Notes payable from discontinued operations $ 52,500 $ 52,500
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.19.1
Note 11 - Stock Transactions (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended
Jan. 03, 2019
Aug. 13, 2018
May 03, 2018
Mar. 06, 2018
Jan. 10, 2018
Mar. 29, 2019
Feb. 15, 2019
Sep. 17, 2018
Jun. 25, 2018
Mar. 30, 2017
Mar. 31, 2019
Dec. 31, 2018
Common stock, shares authorized                     800,000,000 800,000,000
ConvertibleNoteTwelveMember                        
Debt Conversion, Converted Instrument, Amount $ 38,000                      
ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Shares Issued                     25,674,344  
ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Shares Issued                     35,446,300  
ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Shares Issued                     44,490,002  
ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Shares Issued                     26,247,619  
ConvertibleNoteThirteenMember                        
Debt Conversion, Converted Instrument, Amount             $ 38,000          
ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Shares Issued                     14,859,260  
ConvertibleNoteFourteenMember                        
Debt Conversion, Converted Instrument, Amount           $ 38,000            
Noteholder                        
Debt Conversion, Converted Instrument, Shares Issued                     146,717,525  
Principal | ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Amount     $ 83,500               $ 53,957  
Principal | ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Amount       $ 126,000             60,000  
Principal | ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Amount         $ 240,000           66,000  
Principal | ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Amount   $ 53,000                 53,000  
Principal | ConvertibleNoteElevenMember                        
Debt Conversion, Converted Instrument, Amount               $ 33,000        
Principal | ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Amount                 $ 53,000   38,000  
Principal | 8% Convertible Note                        
Debt Conversion, Converted Instrument, Amount                   $ 75,000    
Principal | Noteholder                        
Debt Conversion, Converted Instrument, Amount                     270,957  
Accrued interest | ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Amount                     4,600  
Accrued interest | ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Amount                     4,342  
Accrued interest | ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Amount                     4,995  
Accrued interest | ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Amount                     2,120  
Accrued interest | ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Amount                     2,120  
Accrued interest | Noteholder                        
Debt Conversion, Converted Instrument, Amount                     $ 18,177  
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.19.1
Note 13 - Concentrations and Credit Risk (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
FDIC $ 250,000  
First Customers [Member] | Sales [Member]    
Concentration percentage 24.00% 30.00%
Second Customers [Member] | Sales [Member]    
Concentration percentage 17.00% 21.00%
One Customer [Member] | Accounts Receivable [Member]    
Concentration percentage 96.00% 100.00%
Third Customer [Member] | Sales [Member]    
Concentration percentage 17.00% 21.00%
Fourth Customer [Member] | Sales [Member]    
Concentration percentage   19.00%
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.19.1
Note 14 - Related Party Transactions (Details Narratives) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Disclosure Text Block [Abstract]    
Amounts due to related parties $ 139,753 $ 145,367
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.19.1
Note 15 - Commitments And Contingencies (Details)
Mar. 31, 2019
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2019 $ 3,380
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.19.1
Note 15 - Commitments and Contingencies (Details Narratives) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Disclosure Text Block [Abstract]    
Rent expense $ 7,728 $ 7,048
Term 3 years  
Base Salary $ 75,000  
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.19.1
Note 16- Subsequent Events (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended
May 15, 2019
Jan. 03, 2019
Aug. 13, 2018
May 03, 2018
Mar. 06, 2018
Jan. 10, 2018
Mar. 29, 2019
Feb. 15, 2019
Sep. 17, 2018
Jun. 25, 2018
Mar. 30, 2017
Mar. 31, 2019
ConvertibleNoteTwelveMember                        
Debt Conversion, Converted Instrument, Amount   $ 38,000                    
ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Shares Issued                       25,674,344
ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Shares Issued                       35,446,300
ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Shares Issued                       44,490,002
ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Shares Issued                       26,247,619
Noteholder                        
Debt Conversion, Converted Instrument, Shares Issued                       146,717,525
Noteholder | Subsequent Event [Member]                        
Debt Conversion, Converted Instrument, Shares Issued 35,966,371                      
ConvertibleNoteThirteenMember                        
Debt Conversion, Converted Instrument, Amount               $ 38,000        
ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Shares Issued                       14,859,260
ConvertibleNoteFourteenMember                        
Debt Conversion, Converted Instrument, Amount             $ 38,000          
Principal | ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Amount       $ 83,500               $ 53,957
Principal | ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Amount         $ 126,000             60,000
Principal | ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Amount           $ 240,000           66,000
Principal | ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Amount     $ 53,000                 53,000
Principal | Noteholder                        
Debt Conversion, Converted Instrument, Amount                       270,957
Principal | Noteholder | Subsequent Event [Member]                        
Debt Conversion, Converted Instrument, Amount $ 55,232                      
Principal | ConvertibleNoteElevenMember                        
Debt Conversion, Converted Instrument, Amount                 $ 33,000      
Principal | ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Amount                   $ 53,000   38,000
Principal | 8% Convertible Note                        
Debt Conversion, Converted Instrument, Amount                     $ 75,000  
Accrued interest | ConvertibleNoteEightMember                        
Debt Conversion, Converted Instrument, Amount                       4,600
Accrued interest | ConvertibleNoteSevenMember                        
Debt Conversion, Converted Instrument, Amount                       4,342
Accrued interest | ConvertibleNoteFiveMember                        
Debt Conversion, Converted Instrument, Amount                       4,995
Accrued interest | ConvertibleNoteTenMember                        
Debt Conversion, Converted Instrument, Amount                       2,120
Accrued interest | Noteholder                        
Debt Conversion, Converted Instrument, Amount                       18,177
Accrued interest | Noteholder | Subsequent Event [Member]                        
Debt Conversion, Converted Instrument, Amount $ 1,691                      
Accrued interest | ConvertibleNoteNineMember                        
Debt Conversion, Converted Instrument, Amount                       $ 2,120
EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 129 188 1 false 53 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://igambit.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://igambit.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://igambit.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://igambit.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) Sheet http://igambit.com/role/ConsolidatedStatementsOfChangesInStockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://igambit.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 6 false false R7.htm 00000007 - Disclosure - Note 1 - Organization and Basis of Presentation Sheet http://igambit.com/role/Note1-OrganizationAndBasisOfPresentation Note 1 - Organization and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://igambit.com/role/Note2-SummaryOfSignificantAccountingPolicies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Note 3 - Going Concern Sheet http://igambit.com/role/Note3-GoingConcern Note 3 - Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Note 4 - Property and Equipment Sheet http://igambit.com/role/Note4-PropertyAndEquipment Note 4 - Property and Equipment Notes 10 false false R11.htm 00000011 - Disclosure - Note 5 - Intangible Assets Sheet http://igambit.com/role/Note5-IntangibleAssets Note 5 - Intangible Assets Notes 11 false false R12.htm 00000012 - Disclosure - Note 6 - Earnings (Loss) Per Common Share Sheet http://igambit.com/role/Note6-EarningsLossPerCommonShare Note 6 - Earnings (Loss) Per Common Share Notes 12 false false R13.htm 00000013 - Disclosure - Note 7 - Stock Based Compensation Sheet http://igambit.com/role/Note7-StockBasedCompensation Note 7 - Stock Based Compensation Notes 13 false false R14.htm 00000014 - Disclosure - Note 8 - Convertible Debt Sheet http://igambit.com/role/Note8-ConvertibleDebt Note 8 - Convertible Debt Notes 14 false false R15.htm 00000015 - Disclosure - Note 9 - Derivative Liability Sheet http://igambit.com/role/Note9-DerivativeLiability Note 9 - Derivative Liability Notes 15 false false R16.htm 00000016 - Disclosure - Note 10 - Note Payable Sheet http://igambit.com/role/Note10-NotePayable Note 10 - Note Payable Notes 16 false false R17.htm 00000017 - Disclosure - Note 11 - Stock Transactions Sheet http://igambit.com/role/Note11-StockTransactions Note 11 - Stock Transactions Notes 17 false false R18.htm 00000018 - Disclosure - Note 12 - Income Taxes Sheet http://igambit.com/role/Note12-IncomeTaxes Note 12 - Income Taxes Notes 18 false false R19.htm 00000019 - Disclosure - Note 13 - Concentrations and Credit Risk Sheet http://igambit.com/role/Note13-ConcentrationsAndCreditRisk Note 13 - Concentrations and Credit Risk Notes 19 false false R20.htm 00000020 - Disclosure - Note 14 - Related Party Transactions Sheet http://igambit.com/role/Note14-RelatedPartyTransactions Note 14 - Related Party Transactions Notes 20 false false R21.htm 00000021 - Disclosure - Note 15 - Commitments and Contingencies Sheet http://igambit.com/role/Note15-CommitmentsAndContingencies Note 15 - Commitments and Contingencies Notes 21 false false R22.htm 00000022 - Disclosure - Note 16 - Subsequent Events Sheet http://igambit.com/role/Note16-SubsequentEvents Note 16 - Subsequent Events Notes 22 false false R23.htm 00000023 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Policies) Sheet http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies Note 2 - Summary of Significant Accounting Policies (Policies) Policies http://igambit.com/role/Note2-SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://igambit.com/role/Note2-SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - Note 4 - Property and Equipment (Tables) Sheet http://igambit.com/role/Note4-PropertyAndEquipmentTables Note 4 - Property and Equipment (Tables) Tables http://igambit.com/role/Note4-PropertyAndEquipment 25 false false R26.htm 00000026 - Disclosure - Note 5 - Intangible Assets (Tables) Sheet http://igambit.com/role/Note5-IntangibleAssetsTables Note 5 - Intangible Assets (Tables) Tables http://igambit.com/role/Note5-IntangibleAssets 26 false false R27.htm 00000027 - Disclosure - Note 6 - Earnings (Loss) Per Common Share (Tables) Sheet http://igambit.com/role/Note6-EarningsLossPerCommonShareTables Note 6 - Earnings (Loss) Per Common Share (Tables) Tables http://igambit.com/role/Note6-EarningsLossPerCommonShare 27 false false R28.htm 00000028 - Disclosure - Note 7 - Stock Based Compensation (Tables) Sheet http://igambit.com/role/Note7-StockBasedCompensationTables Note 7 - Stock Based Compensation (Tables) Tables http://igambit.com/role/Note7-StockBasedCompensation 28 false false R29.htm 00000029 - Disclosure - Note 8 - Convertible Debt (Tables) Sheet http://igambit.com/role/Note8-ConvertibleDebtTables Note 8 - Convertible Debt (Tables) Tables http://igambit.com/role/Note8-ConvertibleDebt 29 false false R30.htm 00000030 - Disclosure - Note 9 - Derivative Liability (Tables) Sheet http://igambit.com/role/Note9-DerivativeLiabilityTables Note 9 - Derivative Liability (Tables) Tables http://igambit.com/role/Note9-DerivativeLiability 30 false false R31.htm 00000031 - Disclosure - Note 15 - Commitments and Contingencies (Tables) Sheet http://igambit.com/role/Note15-CommitmentsAndContingenciesTables Note 15 - Commitments and Contingencies (Tables) Tables http://igambit.com/role/Note15-CommitmentsAndContingencies 31 false false R32.htm 00000032 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details) Sheet http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetails Note 2 - Summary of Significant Accounting Policies (Details) Details http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables 32 false false R33.htm 00000033 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details 1) Sheet http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetails1 Note 2 - Summary of Significant Accounting Policies (Details 1) Details http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 00000034 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details 2) Sheet http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetails2 Note 2 - Summary of Significant Accounting Policies (Details 2) Details http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables 34 false false R35.htm 00000035 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Narratives) Sheet http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarratives Note 2 - Summary of Significant Accounting Policies (Details Narratives) Details http://igambit.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 00000036 - Disclosure - Note 3 - Going Concern (Details Narrative) Sheet http://igambit.com/role/Note3-GoingConcernDetailsNarrative Note 3 - Going Concern (Details Narrative) Details http://igambit.com/role/Note3-GoingConcern 36 false false R37.htm 00000037 - Disclosure - Note 4 - Property and Equipment (Details) Sheet http://igambit.com/role/Note4-PropertyAndEquipmentDetails Note 4 - Property and Equipment (Details) Details http://igambit.com/role/Note4-PropertyAndEquipmentTables 37 false false R38.htm 00000038 - Disclosure - Note 4 - Property and Equipment (Details Narrative) Sheet http://igambit.com/role/Note4-PropertyAndEquipmentDetailsNarrative Note 4 - Property and Equipment (Details Narrative) Details http://igambit.com/role/Note4-PropertyAndEquipmentTables 38 false false R39.htm 00000039 - Disclosure - Note 5 - Intangible Assets (Details) Sheet http://igambit.com/role/Note5-IntangibleAssetsDetails Note 5 - Intangible Assets (Details) Details http://igambit.com/role/Note5-IntangibleAssetsTables 39 false false R40.htm 00000040 - Disclosure - Note 5 - Intangible Assets (Details Narrative) Sheet http://igambit.com/role/Note5-IntangibleAssetsDetailsNarrative Note 5 - Intangible Assets (Details Narrative) Details http://igambit.com/role/Note5-IntangibleAssetsTables 40 false false R41.htm 00000041 - Disclosure - Note 6 - Earnings (Loss) Per Common Share (Details) Sheet http://igambit.com/role/Note6-EarningsLossPerCommonShareDetails Note 6 - Earnings (Loss) Per Common Share (Details) Details http://igambit.com/role/Note6-EarningsLossPerCommonShareTables 41 false false R42.htm 00000042 - Disclosure - Note 7 - Stock Based Compensation (Details) Sheet http://igambit.com/role/Note7-StockBasedCompensationDetails Note 7 - Stock Based Compensation (Details) Details http://igambit.com/role/Note7-StockBasedCompensationTables 42 false false R43.htm 00000043 - Disclosure - Note 7 - Stock Based Compensation (Details 1) Sheet http://igambit.com/role/Note7-StockBasedCompensationDetails1 Note 7 - Stock Based Compensation (Details 1) Details http://igambit.com/role/Note7-StockBasedCompensationTables 43 false false R44.htm 00000044 - Disclosure - Note 7 - Stock Based Compensation (Details 2) Sheet http://igambit.com/role/Note7-StockBasedCompensationDetails2 Note 7 - Stock Based Compensation (Details 2) Details http://igambit.com/role/Note7-StockBasedCompensationTables 44 false false R45.htm 00000045 - Disclosure - Note 7 - Stock Based Compensation (Details 3) Sheet http://igambit.com/role/Note7-StockBasedCompensationDetails3 Note 7 - Stock Based Compensation (Details 3) Details http://igambit.com/role/Note7-StockBasedCompensationTables 45 false false R46.htm 00000046 - Disclosure - Note 8 - Convertible Debt (Details) Sheet http://igambit.com/role/Note8-ConvertibleDebtDetails Note 8 - Convertible Debt (Details) Details http://igambit.com/role/Note8-ConvertibleDebtTables 46 false false R47.htm 00000047 - Disclosure - Note 8 - Convertible Debt (Details Narrative) Sheet http://igambit.com/role/Note8-ConvertibleDebtDetailsNarrative Note 8 - Convertible Debt (Details Narrative) Details http://igambit.com/role/Note8-ConvertibleDebtTables 47 false false R48.htm 00000048 - Disclosure - Note 9 - Derivative Liability (Details) Sheet http://igambit.com/role/Note9-DerivativeLiabilityDetails Note 9 - Derivative Liability (Details) Details http://igambit.com/role/Note9-DerivativeLiabilityTables 48 false false R49.htm 00000049 - Disclosure - Note 10 - Note Payable (Details Narratives) Sheet http://igambit.com/role/Note10-NotePayableDetailsNarratives Note 10 - Note Payable (Details Narratives) Details http://igambit.com/role/Note10-NotePayable 49 false false R50.htm 00000050 - Disclosure - Note 11 - Stock Transactions (Details Narrative) Sheet http://igambit.com/role/Note11-StockTransactionsDetailsNarrative Note 11 - Stock Transactions (Details Narrative) Details http://igambit.com/role/Note11-StockTransactions 50 false false R51.htm 00000051 - Disclosure - Note 13 - Concentrations and Credit Risk (Details Narrative) Sheet http://igambit.com/role/Note13-ConcentrationsAndCreditRiskDetailsNarrative Note 13 - Concentrations and Credit Risk (Details Narrative) Details http://igambit.com/role/Note13-ConcentrationsAndCreditRisk 51 false false R52.htm 00000052 - Disclosure - Note 14 - Related Party Transactions (Details Narratives) Sheet http://igambit.com/role/Note14-RelatedPartyTransactionsDetailsNarratives Note 14 - Related Party Transactions (Details Narratives) Details http://igambit.com/role/Note14-RelatedPartyTransactions 52 false false R53.htm 00000053 - Disclosure - Note 15 - Commitments And Contingencies (Details) Sheet http://igambit.com/role/Note15-CommitmentsAndContingenciesDetails Note 15 - Commitments And Contingencies (Details) Details 53 false false R54.htm 00000054 - Disclosure - Note 15 - Commitments and Contingencies (Details Narratives) Sheet http://igambit.com/role/Note15-CommitmentsAndContingenciesDetailsNarratives Note 15 - Commitments and Contingencies (Details Narratives) Details http://igambit.com/role/Note15-CommitmentsAndContingenciesTables 54 false false R55.htm 00000055 - Disclosure - Note 16- Subsequent Events (Details Narrative) Sheet http://igambit.com/role/Note16-SubsequentEventsDetailsNarrative Note 16- Subsequent Events (Details Narrative) Details 55 false false All Reports Book All Reports igmb-20190331.xml igmb-20190331.xsd igmb-20190331_cal.xml igmb-20190331_def.xml igmb-20190331_lab.xml igmb-20190331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 72 0001607062-19-000235-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001607062-19-000235-xbrl.zip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�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